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Abstract
Eleven fatty acid analogs incorporating four-membered carbocycles (cyclobutenes, cyclobutanes,
cyclobutanones, and cyclobutanols) were investigated for the ability to inhibit growth of
Mycobacterium smegmatis (Msm) and Mycobacterium tuberculosis (Mtb). A number of the
analogs displayed inhibitory activity against both mycobacterial species in minimal media. Several
of the molecules displayed potent levels of inhibition against Mtb with MIC values equal to or
below those obtained with the anti-tuberculosis drugs D-cycloserine and isoniazid. In contrast, two
of the analogs displaying the greatest activity against Mtb failed to inhibit E. coli growth under
either set of conditions. Thus, the active molecules identified here (1, 2, 6, and 8) may provide the
basis for development of anti-mycobacterial agents against Mtb.
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Introduction
Tuberculosis resulting from Mycobacterium tuberculosis (Mtb) infection remains one of
mankind’s most significant disease threats. Based on skin test reactivity, it is estimated that
one-third of the world’s population has been exposed, resulting annually in approximately
nine million incident cases and 1.4 million deaths (2010 data).[1] A number of therapeutic
agents have been developed, but current treatment regimens require patients to take multiple
drugs over a period of months and are associated with significant side effects.[2] The result
is frequent patient noncompliance, leading to relapses and the emergence of drug resistance,
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with a high fraction of active cases now involving multi-drug resistant (MDR, XDR)
strains.[1] There is, therefore, a need for new classes of therapeutics for tuberculosis.[3]
Importantly, the lethal target and/or the mechanism of action should also be novel to avoid
established mechanisms of resistance and provide synergy with existing treatments.
Much of the hardiness and drug resistance of mycobacteria is due to an unusually thick lipid
cell wall containing a significant proportion of mycolic acids, a unique class of C54–C63
branched-chain fatty acids.[4] A number of existing treatments for Mtb, exemplified by
isoniazid and ethionamide, disrupt mycolic acid biosynthesis by inhibiting important
biosynthetic enzymes.[5] Mycobacteria incorporate intact C16 and C18 fatty acid skeletons as
biosynthetic feed stocks and given the prior evidence for the incorporation of modified fatty
acids into mycolic acid biosynthesis,[6] we hypothesized that hijacking this pathway could
provide a unique approach for the development of potential therapeutics.[4] Towards this
end, we proposed to investigate specifically functionalized fatty acids for their ability to
limit mycobacterial growth.[7] As our first steps towards validating this hypothesis, we
investigated two series of fatty acid analogs (Figure 1). One series (1–4) was based upon a
decenoic acid (10:1) framework and a second series (5–11) based upon the frameworks of
oleic or elaidic acids (18:1). The analogs preserve the approximate lengths and cross-
sections of the “parent” fatty acids while incorporating four-membered carbocycles into the
backbone. We now report that several of these analogs display significant anti-
mycobacterial activity against Mtb.
Results and Discussion
Substrate Preparation
The only previous description of molecules included in this study was the preparation of a
mixture of the methyl esters of 5 and 10 via a nonselective radical decarboxylation.[8] In
search of an efficient, general, and stereospecific approach to incorporation of four-
membered rings onto a fatty acid backbone, we were drawn to methodology for
modification of dichlorocyclobutanones.[9] Our approach is illustrated in detail for the
preparation of analogs 1–4 (Scheme 1). The benzyl ester of 9-decenoic acid underwent
cycloaddition with dichloroketene to afford one major dichlorobutanone (15),[10] which was
only moderately stable towards purification, and was therefore directly reduced with sodium
borohydride to furnish a mixture of stereoisomeric 2,2-dichloro-1-cyclobutanols. The choice
of sodium borohydride was for convenience as a similar product mixture is available using
other reducing reagents such as BH3·THF and Na(OAc)3BH. The alcohols were converted
to the corresponding methanesulfonate (mesylate) esters (16). Reaction with sodium in
ammonia resulted in simultaneous reductive cleavage of the benzyl ester and fragmentation/
reduction of the β-chloro methanesulfonate to furnish cyclobutene 1. Hydrogenation of 1
cleanly generated cyclobutane 2. Alternatively, dehalogenation of initial cycloadduct 15
with zinc in acetic acid, followed by deprotection of the benzyl ester with Pd(C)/H2,
furnished cyclobutanone 3. Hydride reduction of the intermediate ketone with hydride prior
to hydrogenolysis generated cyclobutanol 4 as a mixture of diastereomers at the newly
created alcohol stereocenter.
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The preparation of analogs incorporating the four-membered ring carbocycles onto a cis C18
framework is illustrated in Scheme 2. In this case, the initial cycloaddition with benzyl
oleate produced an inseparable mixture of regioisomeric dichlorocyclobutanones (19). The
cycloadducts, which were prone to decomposition during purification, were directly reduced
to furnish a mixture of regioisomeric 2,2-dichloro-1-cyclobutanols. The corresponding
methanesulfonate (mesylate) esters (20) underwent reduction/fragmentation as described
above to furnish the cyclobutene 5,[8] which could be hydrogenated to cyclobutane 6. The
related cyclobutanone (7) and cyclobutanol (8) were prepared from the
dichlorocyclobutanone in a similar manner as described earlier for the C10 series.
Alternatively, controlled dehalogenation of the dichlorocyclobutanone cycloadduct with
stoichometric Zn or Zn(Cu) in acetic acid furnished a mixture of regioisomeric
monochlorocyclobutanones (22) contaminated by small amounts of dichloroketone (starting
material) and cyclobutanone 3 (overreduction).[11] Hydrogenolysis of the monochlorocyclo
butanone as before furnished analog 9.
The ready availability of elaidic acid, a C18 fatty acid containing a trans-9,10 alkene, made
it possible to investigate the influence of stereoisomers (Scheme 3). Beginning with elaidic
acid (14) we were able to synthesize cyclobutene 10 and monochlorocyclobutanone 11 in a
manner analogous to that described previously for oleate-derived substrates 5 and 9. The
only major difference from the route employed in Scheme 2 was the need to employ
activated Zn or Zn/Cu for the initial ketene generation/cycloaddition.[12]
Inhibitor stability and solubility
Analogs 1 – 11 were each tested for thermal stability using differential scanning calorimetry
(DSC) in tandem with thermal gravimetric analysis (TGA); details are provided in the
Supporting Information. Although we originally had concerns for the stability of the
cyclobutene-containing analogs (1, 5, and 10) towards thermally induced cycloreversion,[13]
we observed no decomposition of any analog below 100 °C; most of the new analogs were
stable to ≥ 150 °C.
One-dimensional (1D) 1H NMR spectroscopy was used to verify the aqueous stability and
solubility for each of the eleven analogs. An example series is illustrated in Figure 2; more
detailed data is provided in Supporting Information. The results demonstrate the analogs to
be stable in aqueous buffer. All of the analogs based upon a C18 scaffold (5–11) display
evidence of aggregation at all concentrations tested (down to 100 mM). In contrast, the
analogs based upon the C10 backbone (1–4) were not observed to aggregate at even mM
concentrations (Table 1).
MIC determination
MICs were determined against the following bacteria: Escherichia coli (E. coli) wild type
strain G58-1; M. smegmatis (Msm) strain mc2155, a non-pathogenic mycobacteria used as a
model for Mtb to analyze processes that are likely to be conserved in the genus; and two Mtb
strains (CDC1551 and H37Rv). Kanamycin (Kan) was used as a positive inhibition control
for E. coli. Isoniazid (Inh), one of the main first-line drugs used to treat TB, and D-
cycloserine (DCS), a second line clinically used TB drug, were employed as controls that
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would allow benchmarking against other inhibitors. Results for the fatty acid analogs are
shown in Table 2.
Neither of the two analogs (1, a C10 cyclobutene and 6, a C18 cyclobutane) tested against E.
coli were inhibitory in rich (LB broth) or minimal media. Interestingly, the susceptibility of
E. coli towards the control drugs (DCS, Inh and Kan) was greater in minimal media as
indicated by the significantly lower MIC values. Preliminary studies indicated that Msm was
not susceptible to compounds 7 and 10 in complete Middlebrook 7H9 broth supplemented
with either Tween or Tyloxapol (data not shown). In this context, a potential interfering
compound is bovine serum albumin that has been shown to bind to fatty acids.[14] Indeed,
preliminary tests using Msm and compound 7 indicate that increasing concentrations of BSA
significantly increase the MIC value (unpublished results). Thus, the entire set of
compounds synthesized was tested in minimal media against Msm and the two Mtb strains.
Under these conditions, none of the compounds demonstrated significant activity against
Msm. However, four (1, 2, 6, and 8) of the eleven compounds yielded MIC values < 100 μM
for both Mtb strains, with two of the compounds (2 and 8) proving superior to DCS on a
molar basis. Importantly, compound 2 yielded MIC values equal (CDC1551 strain) or
superior (H37Rv strain) to those obtained with Inh. In summary, these compounds were
poor inhibitors of Msm but quite effective against Mtb grown in minimal media.
Nonspecific toxicity
A sampling of six analogs, along with decanoic acid (12) and the Mtb therapeutics isoniazid
and DCS, were investigated for toxicity in RAW 264.7 macrophages. SDS was employed as
a positive control for maximum toxic effect. As illustrated in Table S1 (see Supporting
Information), three of the tested analogs (4, 5, and 6), as well as DCS and isoniazid showed
little or no toxicity at concentrations below 250 μM;[15] toxicity for 12 was only slightly
greater. Modest or significant toxicity was observed for analogs 1, 2, and 8
Discussion
The MIC results demonstrate promising levels of inhibition with a variety of four-membered
ring carbocycles (cyclobutanol, cyclobutanone, cyclobutene, and cyclobutane). A critically
important component of evaluating new and potentially promising therapeutic entities is
validation of a drug-like mode of action. Unfortunately, there are numerous undesirable
mechanisms resulting from poor physical behavior of a compound that will result in a false
positive in a biological assay. These poor properties may include insolubility, reactivity,
micelle formation, impurities, aggregation, instability and non-specific binding. This has
resulted in numerous compounds erroneously reported as chemical leads that are not
acceptable drug candidates because of these undesirable physiochemical properties.[16] The
fatty acid analogs discussed here are thermally stable. All of the analogs based upon a C18
backbone aggregate at concentrations overlapping the MIC values observed for Mtb or Msm.
Correspondingly, the biological mechanism of action for analogs 5 to 11 is suspect and these
analogs are unlikely to be viable drug-leads. The propensity for these compounds to form
micelles or aggregate at concentrations lower than their MIC values must also be considered
in any attempt to extract structure-activity relationships. In contrast, the analogs based upon
a C10 backbone (1–4) displayed no sign of aggregation at concentrations up to 1000 μM,
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levels well above the measured MICs (Figure 3). The observation of significant and superior
inhibition of Mtb with compounds from the shorter chain series provides strong evidence
that the inhibition is specific and not simply due to the general toxicity often observed with
very hydrophobic substrates.[16] Although some short-chain fatty acids have also
demonstrated limited antimicrobial activity,[7] Mtb is also reported to use decanoic acid
(10:0) as a carbon source[17] Moreover, decenoic acid (12), the parent 10:1 framework of
our shorter chain analogs, demonstrated very modest levels of inhibition in Mtb. Finally, we
note that the extremely hydrophobic oleic acid (13), the parent 18:1 framework of analogs
5–9, is used as a standard nutrient for Mtb at 0.05 g/L (177 μM), a concentration higher than
the MICs of the best inhibitors. Nonetheless, oleic acid is always used in media containing
bovine serum albumin that may ameliorate its toxicity.[14]
The nature of the functionality has a clear impact on activity. Within the less hydrophobic
short-chain series (compounds 1–4), the measured MICs vary by more than sixty fold
against Mtb H37Rv and more than thirty fold against strain CDC1551. In contrast, less than
a ten-fold difference is observed for MICs measured against Msm. Although the potential for
micelle formation is cause for caution in making structure-activity comparisons involving
the long chain series, the different influences of a given functional group within the C18 and
C10 series are interesting. For example, the short-chain cyclobutanone (3) and cyclobutanol
(4) are much less potent toward Mtb than the corresponding long-chain analogs (7 and 8),
while the values for the cyclobutenes (1 vs. 5 or 10) are similar. The influence of
stereochemistry varies by analog. The MICs for the cis and trans isomers of the C18
monochloroketones (9 and 11) differ by more than ten-fold for Mtb (H37Rv); in contrast, no
difference is seen between the cis- and trans-cyclobutenes (5 and 10) with either Mtb strain.
Finally, we note that in both the C18 and C10 series, the saturated analogs (cyclobutanes 6
and 2) are considerably more potent than the corresponding cyclobutenes (5 and 1).
Comparing MIC values obtained against Mtb vs. Msm, ten of eleven analogs demonstrate
lower MIC values in at least one strain of Mtb compared with Msm; for six of the eleven,
lower MIC values are obtained against both strains of Mtb. The ratio of MIC values for Mtb
vs. Msm ranges from less than one to over six hundred; viewed across the eleven analogs,
the average ratio of MICs for Mtb vs Msm is sixty eight (CDC1551) and nearly ninety
(H37Rv). The different levels of inhibition produced in Msm and Mtb may result from a
mechanism of action specific to Mtb. Isoniazid, for example, demonstrates 100-fold more
potent inhibition of Mtb compared with Msm and possesses low toxicity toward other
mycobacteria and prokaryotic pathogens.[21] The lack of inhibition observed in E. coli using
two of the analogs (1 and 6) most potent against Mtb could indicate specific inhibition of a
metabolic pathway unique to the latter.
The initial hypothesis behind the design of the molecules reported here was that uptake of a
fatty acid analog bearing a reactive functional group (for example, cyclobutene,
cyclobutanone, chloroketone) might disrupt an enzymatic process related to cell wall
synthesis. We imagined that one such target might be methyl transferases, which are
common in mycobacteria, but relatively uncommon in other organisms.[18] In an earlier
example of a related approach, the inhibition of growth in Mtb observed in the presence of
alkyne-containing fatty acids (MICs of 20–25 μM) was attributed to irreversible
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modification of an enoyl reductase within the mycobacterial FASII system.[4,7] However,
the significant inhibition produced by cyclobutanes 2 and 6, which lack a chemically
reactive group, is more suggestive of a noncovalent mode of inhibition. The relatively low
MIC values indicate our fatty acid analogs have promise as anti-mycobacterial agents, but
there is still a need to confirm cellular uptake and to establish the in vivo target.
A variety of carbocyclic fatty acids including cyclopropyl, cyclopentyl, cyclohexyl and
cycloheptyl fatty acids are found in bacteria and plants.[19] Their roles, while not always
completely understood, may be related to control of membrane fluidity.[20] In the case of
mycobacteria, the presence of cyclopropane subunits in mycolic acids is known to be
associated with the structural integrity of the cell wall and the ability of the tubercle bacillus
to resist oxidative stress inside macrophages. In contrast, cyclobutane fatty acids are rare.
An unusual fatty acid incorporating a ladder-type structure of fused cyclobutanes, recently
isolated from anammox bacteria found near undersea vents, is believed to contribute to the
formation of dense and impermeable lipid membranes that protect the bacteria from harsh
chemical environments.[19] Thus, as an alternative to disrupting mycolic acids biosynthesis,
it is also plausible that our four-membered ring analogs are converted into analogs of
mycolic acids and that the physical properties of these unnatural cell wall constituents
results in cell death. However, it must be noted that while mycobacteria are known to
directly incorporate structurally modified fatty acid feedstocks into mycolic acid
biosynthesis,[6] there is as yet no evidence that the same is true for the specific fatty acid
analogs described here.[7] Indeed, further studies will be required in order to determine an in
vivo mechanism of inhibition for our compounds.
In this context, it is worth noting that our initial choice of molecular scaffold was based
upon the availability of low-cost precursors. If the modified fatty acid chains are indeed
taken up into the mycobacterial biosynthetic pathways, greater activity or different
specificities might be identified through the use of different molecular backbones or
alternative positioning of the four-membered ring carbocycles.
Conclusion
Analogs of fatty acids incorporating four-membered ring carbocycles may provide a starting
point for the development of new antimycobacterials. Four of eleven analogs tested yielded
MIC values < 100 μM for both Mtb strains, with two of the analogs proving more active
than DCS and one analog proving equally potent or superior to Inh, one of the main first-line
drug used for treatment of tuberculosis.
Experimental Section
General procedures
All reagents and solvents were used as purchased except for pyridine and CH2Cl2 (distilled
from CaH2 and kept under N2) and THF (distilled from Na/benzophenone under N2).
Reactions were performed under a N2 atmosphere unless stated otherwise. Thin-layer
chromatography (TLC) was performed on 0.25 mm hard-layer silica G plates; developed
plates were visualized with a hand-held UV lamp or by staining: 1% Ce(SO4)2 and 10%
Sittiwong et al. Page 6













(NH4)2MoO4 in 10% aq. H2SO4 (general stain, after heating); 1% aq. KMnO4 (for
unsaturated compounds); 3% vanillin in 3% H2SO4 in EtOH (general stain, after heating).
Unless otherwise noted, NMR spectra were recorded at 400 MHz (1H) or 100 MHz (13C) in
CDCl3; peaks are reported as: chemical shift (multiplicity, J couplings in Hz, number of
protons); “app” and “br” refer to apparent and broad signals, respectively. IR spectra were
recorded as neat films (ZnSe, ATR mode) with selected absorbances reported in
wavenumbers (cm−1). Flash chromatography was performed on 32–60 μm silica gel.
Preparative HPLC was performed on a 21 × 250 mm normal phase Si (8 micron) column at
10 mL/min of the indicated solvent unless otherwise noted. Analytical purity of compounds
was checked using an analytical column (250 mm × 4.6 mm; Microsorb) at 1 mL/min of
20% EtOAc/Hexane; detection was accomplished using a differential refractometer
interfaced with a data module. All compounds tested for biological activity showed >97%
purity by HPLC analysis except for 5 and 7. Melting points are uncorrected.
3-(Octanoic acid, 8-yl, benzyl ester) 2,2-dichlorocyclobutanone (15) was prepared
similarly to compound 23 and afforded (13.8 g, 80%) as a brown oil from benzyl 9-
decenoate (12.4 g, 48 mmol), trichloroacetyl chloride (10.7 mL, 95 mmol), and Zn(Cu)
(15.55 g, 238 mmol) in ether 0.1 M (340 mL). Consistent with a previous report, only one
isomer was observed.[22] The assignment was confirmed by observation of the pair of
geminal hydrogens adjacent to the ketone at δ 3.33 and 2.94 by 1H-NMR and by the
observation of eleven rather than twelve carbons (symmetry) upon dechlorination to
cyclobutanone 3: Rf = 0.34 (10% EtOAc/Hex); IR: 2935, 2852, 1814, 1730, 905, 725
cm−1; 1H NMR: δ 7.39-7.29 (m 5H), 5.12 (s, 2H), 3.33 (dd, J = 9.4, 17.2, Hz, 1H), 2.94 (dd,
J = 9.0, 17.2 Hz, 1H), 2.88-2.81 (m, 1H), 2.37/2.36 (overlapping t, J = 7.5 Hz, 2H),
1.94-1.84 (m, 1H), 1.70-1.72 (m, 3H), 1.46-1.28 (m, 8H); 13C NMR: δ 192.8,173.4, 136.0,
128.4, 128.0, 88.8, 65.9, 47.7, 45.8, 34.1, 31.2, 29.0, 28.9, 28.8, 27.2, 24.7; HREI-MS calcd.
for C19H25O3Cl2: [M+H]+ 371.1181; found: 371.1188.
3-(Octanoic acid, 8-yl, benzyl ester) 2,2-dichlorocyclobutanol, methanesulfonate ester
(16) was prepared similarly to compound 20 from the previous dichloroketone 15 (10.0 g,
26.9 mmol), NaBH4 (1.53 g, 40.4 mmol), and iPrOH (350 mL). The crude product was
purified by flash column chromatography with 10% EtOAc/Hex to furnish the
dichlorobutanol (5.76 g, 57%) as a colorless oil: Rf = 0.39 (20% EtOAc/Hex); IR: 3440 (br),
2927, 2854, 1733, 1164, 960, 697 cm−1; 1H NMR: δ 7.40-7.30 (m 5H), 5.12 (s, 2H),
4.73-4.64 (m, 0.1H) 4.34-4.27 (m, 0.9H), 2.97 (d, J = 8.2 Hz, 0.1H, OH is trans to
backbone), 2.87 (d, J = 10.3 Hz, 0.9H, OH is cis to backbone), 2.48-2.34 (m, 1H), 2.36 (t, J
= 7.6 Hz, 2H), 1.78-1.60 (m, 3H), 1.53-1.28 (m, 11H); 13C NMR: δ 173.7, 136.0, 128.5,
128.1, 92.9, 75.4, 66.1, 45.6, 34.5, 34.2, 29.8, 29.2, 29.0, 28.9, 26.5, 24.8; HRESI-MS calcd.
for C19H23O3Cl2 [M+Na]+: 395.1157; found: 395.1151.
Conversion to the methanesulfonate was performed as described for compound 20, using
methanesulfonyl chloride (20 mL, 29.4 mmol), the dichlorobutanol (5.50 g, 14.7 mmol), and
triethylamine (9.20 mL, 66.3 mmol) in CH2Cl2 (70 mL). The crude product was purified by
flash chromatography (10% EtOAc/Hex) to afford 16 as a light yellow oil (6.13 g, 92%): Rf
= 0.36 (20% EtOAc/Hex); IR: 2927, 2858, 1731, 1364, 1179, 952 cm−1; 1H NMR: δ
7.36-7.31 (m 5H), 5.11 (s, 2H), 5.13-5.09 (m, 1H), 3.18 (s, 3H), 2.56-2.50 (m, 2H), 2.35 (t, J
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= 7.6 Hz, 2H), 1.93-1.28 (m, 13H); 13C NMR: δ 173.5, 136.0, 128.4, 128.1, 88.4, 78.3, 66.0,
45.8, 39.3, 34.1, 31.6, 29.8, 29.1, 28.87, 28.85, 26.2, 24.8; HRESI-MS calcd. for
C20H28O5Cl2SNa [M+Na]+: 473.0932; found: 473.0930.
8-(2-Cyclobuten-1-yl)-octanoic acid (1) was prepared by a similar procedure as employed
for 5 via reaction of Na metal (2.80 g, 120 mmol) with a solution of 5.40 g (12.0 mmol) of
the mixture of methanesulfonate 16 in THF (30 mL) and NH3 (~ 250 mL). The crude
product was purified by flash column chromatography (2% EtOAc/Hex) to afford 9,10-
ethenooctadecanoic acid 1 (1.64 g, 52 %) as a low-melting white solid: Rf = 0.47 (6:4:0.05
of Hex:EtOAc:AcOH); m.p. = 20–21 °C; IR: 3112 (br), 3043, 2920, 2853, 1705, 697
cm−1; 1H NMR: δ 10.27 (br s,1H, COOH), 6.11 (br d, J = 2.4 Hz, 1H), 6.04 (br dd, J = 0.8,
2.0 Hz, 1H), 2.77 (m, 1H), 2.66 (ddd, J = 0.8, 4, 13.2 Hz, 1H), 2.35 (t, J = 7.2 Hz, 2H), 2.04
(d, J = 13.2 Hz, 1H), 1.64 (quintet, J = 7.2 Hz, 2H), 1.51-1.38 (br m, 2H), 1.38-1.23 (br m,
8H); 13C NMR: δ 180.0, 141.1, 135.1, 44.2, 36.9, 34.6, 34.0, 29.5, 29.2, 29.0, 27.9, 24.7;
HRESI-MS calcd. for C12H20O2Na [M+Na]+: 219.1361; found: 219.1355. Purity 100% by
HPLC (retention time, 5.01 min).
8-Cyclobutyloctanoic acid (2) was prepared by a similar procedure as for 6 from the
hydrogenation of cyclobutene 1 (0.034, 0.170 mmol), over 10% Pd/C (0.034 g, 0.030 mmol)
in EtOAc (1.7 mL) to afford the unprotected acid 2 (0.030 g, 89%) as a low-melting white
solid: Rf = 0.47 (6:4:0.05 of Hex:EtOAc:AcOH); m.p. = 28–30 °C; IR: 3035 (br), 2916,
2849, 1695, 909, 733 cm−1; 1H NMR: δ 11.34 (br s, 1H, COOH), 2.37 (t, J = 7.2, 2H), 2.25
(septet, J = 7.2, 1H), 2.10-1.98 (m, 2H), 1.90-1.75 (m, 2H), 1.70-1.52 (m, 2H), 1.40-1.12 (br
m, 10H); 13C NMR: δ 180.3, 37.0, 36.2, 34.1, 29.4, 29.2, 29.0, 28.4, 27.1, 24.7, 18.5; HRCI-
MS calcd. for C12H22O2: [M+H]+ 199.1698; found: 199.1695. Purity > 99% by HPLC
(retention time, 4.92 min).
3-(Octanoic acid benzyl ester, 8-yl) cyclobutanone (17) was prepared in a similar manner
as 21, via reaction of dichloroketone 15 (1.05 g, 2.69 mmol), 6 mL of glacial acetic acid, and
Zn(Cu) (1.76 g, 26.9 mmol). The product was purified by flash chromatography (10%
EtOAc/Hex) to afford a colorless oil (0.4859 g, 59%) which was a mixture of regioisomers:
Rf = 0.55 (20% EtOAc/Hex). IR: 2923, 2854, 2780, 2732, 1163, 730, 697 cm−1; 1H NMR: δ
7.35-7.28 (br m, 5H), 5.09 (s, 2H), 3.13-3.03 (m, 2H), 2.65-2.57 (m, 2H), 2.33 (t, J = 7.2,
2H), 2.33-2.26 (m, 1H), 1.68-1.58 (br quintet, J = 6.4, 2H), 1.58-1.48 (br q, J = 7.2, 2H),
1.29 (br s, 8H); 13C NMR: δ 208.2, 173.3, 134.0, 128.3, 127.9, 65.8, 52.3, 36.1, 34.0, 28.9,
28.8, 28.0, 24.7, 23.6; HRESI-MS calcd. for C19H26O3Na [M+Na]+: 325.1780; found:
325.1775.
3-(Octanoic acid, 8-yl) cyclobutanone (3) was prepared by a similar procedure as for 7
through reaction of benzyl ester 17 (0.0346, 0.1 mmol), 10% Pd/C (0.020 g, 0.02 mmol) and
EtOAc (1 mL). The product was purified by flash column chromatography on silica gel (step
gradient of 20%/40% EtOAc/Hex) to afford acid 3 (0.0189 g, 90%) as a low-melting white
solid: Rf = 0.3 (6:4:0.05 of Hex:EtOAc:AcOH); m.p. = 35–37 °C; IR: 3094 (br), 2923, 2853,
1780, 1705 cm−1; 1H NMR: δ 10.61 (br s, 1H, COOH), 3.17-3.08 (m, 2H), 2.69-2.61 (m,
2H), 2.35 (br t, J = 7.6, 2H), 2.39-2.31 (br, 1H), 1.69-1.53 (br m, 4H), 1.32 (br s, 8H); 13C
NMR: δ 208.8, 179.9, 52.5, 36.3, 34.0, 29.2, 29.1, 28.9, 28.2, 24.6, 23.8; HRCI-MS calcd.
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for C12H20O3Na [M+Na]+: 213.1491; found: 213.1490. Purity > 97% by HPLC (retention
time, 10.75 min).
3-(Octanoic acid benzyl ester) cyclobutanol (18) was prepared by a similar procedure as
compound 8 via reaction of cyclobutanone 17 (0.0509 g, 0.17 mmol) and NaBH4 (0.013 g,
0.34 mmol) in anhydrous MeOH (2.5 mL). 18 (after purification by flash column
chromatography with 20% EtOAc/Hex) was isolated as a low-melting white solid (0.040 g,
76%). The product was a 9:1 mixture of cis/trans stereoisomers based on the previous
assignments for cyclobutanol 8. Rf = 0.29 (20% EtOAc/Hex); m.p. = 30–31 °C; IR: 3356
(br), 2922, 1734, 1154, 735, 696 cm−1; 1H NMR: δ 7.40-7.30 (m, 5H), 5.11 (s, 2H),
4.42-4.34 (br m, 0.1H), 4.14-4.03 (br m, 0.9H), 2.48-2.40 (m, 0.18H), 2.35 (t, J = 7.2,
0.18H), 2.16-2.04 (m, 0.2H), 1.95 (t, J = 6.6, 0.2H), 1.70-1.56 (br m, 3H), 1.48-1.13 (br m,
12H); 13C NMR: δ 173.6, 136.0, 128.4, 128.1, 66.0, 63.7, 39.7, 37.0, 34.2, 29.2, 29.1, 29.0,
27.3, 25.4, 24.82; HRCI-MS calcd. for C19H29O3Na [M+Na]+: 305.2117; found: 305.2116.
3-(Octanoic acid) cyclobutanol (4) was prepared by a similar procedure as employed for 8
through reaction of benzyl ester 18 (0.034g, 0.110 mmol), 10% Pd/C (0.024 g, 0.022 mmol)
and EtOAc (1 mL). The crude product was purified by flash column chromatography (40%
EtOAc/Hex) to afford acid 4 (0.013 g, 54%) as a white solid: Rf = 0.24 (6:4:0.05 of
Hex:EtOAc:AcOH); m.p. = 74-75 °C; IR: 3341 (br), 2916, 2849, 1695, 1064 cm−1; 1H NMR
(MeOD): δ 4.30 (quintet, J = 6.8, 0.1H), 4.01 (quintet, J = 6.4, 0.9H), 2.45-2.35 (br m, 2H),
2.29 (t, J = 7.2, 2H), 1.75-1.55 (br m, 3H), 1.50-1.15 (br m, 12H); 13C NMR (MeOD): δ
176.3, 62.8, 38.9, 36.9, 36.8, 33.6, 29.1, 29.0, 28.8, 27.1, 25.4, 24.7; HRESI-MS calcd. for
C12H22O3Na [M+Na]+: 237.1467 found: 237.1460. Purity > 97% by HPLC (retention time,
9.65 and 11.36 min).
2,2-Dichloro-4-(octanoic acid benzyl ester, 8-yl) 3-octylcyclobutanone-; 2,2-Dichloro-3-
(octanoic acid benzyl ester, 8-yl) 4-octylcyclobutanone (19) was prepared by a
modification of a known procedure.[22–24] To a mixture of zinc dust (0.879 g, 13.4 mmol)
and benzyl oleate 19 (1.02 g, 2.73 mmol) in 20 mL of anhydrous ether was slowly added a
solution of trichloroacetyl chloride (0.75 mL, 6.8 mmol) in 7 mL of diethyl ether via
dropping funnel over a period of 45 min. The reaction was stirred until judged complete by
the absence of starting material (4 h, TLC). The reaction mixture was filtered through a plug
of Celite and the residue was washed with ether (2 × 75 mL). The organic solution was
stirred a minimum with 50% aq. NaHCO3 and the separated aqueous layer back-extracted
with ether (2 × 20 mL). The combined organic layers were dried over Na2SO4 and
concentrated under vacuum to give g of the product (1.30 g, 99%) as a yellow oil. The
unpurified material was generally used directly for the next reaction because of a tendency
to decompose during chromatography. However, small quantities could be purified by rapid
flash chromatography (5% EtOAc/Hex) to afford a 1:1 mixture of regioisomeric
dichlorocyclobutanones 19 as a colorless oil: Rf = 0.53 (10% EtOAc/Hex); IR: 2926, 2855,
1800, 1735, 1456, 1162, 696 cm−1; 1H NMR: δ 7.36-7.32 (5H), 5.120/5.116 (overlapping s,
2H), 3.55-3.49 (m, 1H) 2.97-2.93 (m, 1H), 2.37/2.35 (overlapping t, J = 7.6 Hz, 2H),
1.74-1.62 (m, 4H), 1.66-1.48 (m, 4H), 1.45-1.27 (br m, 18H), 0.89/0.88 (overlapping
triplets, J = 6.9 Hz, total 3H); 13C NMR: δ 197.5, 173.5, 136.1, 128.5, 128.1, 88.1, 66.0,
58.0, 57.9, 49.4, 49.4, 34.2, 31.8, 31.80, 29.60, 29.3, 29.3, 29.2, 29.18, 29.15, 29.12, 29.0,
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28.9, 28.9, 28.04, 27.96, 26.72, 26.68, 26.3; HRFAB-MS (3-NBA+Li matrix: calcd. for
C27H40O3Cl2Li [M+Li]+:489.2515; found: 489.2499.
2,2-Dichloro-4-(octanoic acid benzyl ester, 8-yl) 3-octylcyclobutanol, methanesulfonate
ester; 2,2-Dichloro-3-(octanoic acid benzyl ester, 8-yl) 4-octylcyclobutanol,
methanesulfonate ester (20). Reduction of the dichlorocylobutanone 19 was achieved using
a modification of a known procedure.[9,24] To a 0 °C solution of dichlorocyclobutanones 19
(1.5 g, 3.1 mmol) in iPrOH (45 mL) was added NaBH4 (0.176 g, 4.65 mmol). The reaction
was allowed to slowly warm to rt and stirred until starting material had disappeared (TLC, ~
2.5h; byproducts tended to accumulate upon prolonged reaction). The reaction was then
cooled to 0 °C and quenched with 1N HCl (40 ml). The solution was stirred for an additional
30 min, concentration to one third the original volume, and then extracted with EtOAc (3 ×
100 mL). The organic layer was washed sequentially with water/sat. NaHCO3/brine and
then dried over Na2SO4. Evaporation of the organic solvent and flash chromatography of the
residue on silica gel, using a step gradient of 5%/10% EtOAc/Hex, gave (0.821 g, 55%
yield) of a 1:1 mixture of regioisomeric cyclobutanols as a colorless oil. The products were
predominantly a regioisomeric mixture of the cis,cis diastereomers[22] based on 1H NMR,
HSQC, 2D-COSY and 2D-NOESY analysis:[25] Rf (10% EtOAc/Hex) = 0.33 (major, OH is
cis to backbone) 0.28 (minor, OH is trans to backbone), 0.2 (major, OH is cis to backbone)
and 0.15 (minor, OH is trans to backbone); IR: 3473, 3036, 2924, 2854, 1733, 1456, 1168,
696 cm−1; 1H NMR: δ 7.36-7.32 (m, 5H), 5.116/5.112 (app s, total 2H), 4.55 (dd, J = 10.8,
8.8 Hz, 0.92H, CH-OH, cis to the backbone assigned based on 2D-NOESY analysis
and 4Jdiagonal H = 0), 3.99 (br t, J = 10 Hz, 0.08H), 2.75-2.69 (m, 1H), 2.64/2.62
(overlapping d, J = 10.8 Hz, total 1H, -OH proton assigned based on the disappearance of
this peak upon D2O addition), 2.60-2.55 (m, 1H), 2.36/2.35 (overlapping t, J = 7.6 Hz, total
2H), 1.67-1.62 (bm, 3H), 1.52-1.19 (24H), 0.89/0.88 (overlapping t, J = 6.8 Hz, total 3H).
Small quantities of the individual isomers could be isolated by semipreparative HPLC (10%
EtOAc/Hex, RI detection):
First-eluting cis—Rf = 0.33; IR: 3457, 2924, 2854, 1736, 1456, 1170, 697 cm−1; 1H
NMR: δ 7.37-7.32 (m, 5H), 5.12 (s, 2H), 4.55 (dd, J = 10.8, 8.8 Hz, 1H, CH-OH, cis to the
backbone assigned based on 2D-NOESY analysis and 4Jdiagonal H = 0), 2.72 (dt, J = 9.2, 5.6
Hz, 1H), 2.59 (d, J = 10.8 Hz, 1H, -OH), 2.55 (app dq, J = 9.2, 5.6 Hz, 1H), 2.36 (t, J = 7.6
Hz, 2H), 1.67-1.51 (br m, 3H), 1.52-1.13 (m, 24H), 0.88 (app t, J = 6.8 Hz, 3H); 13C NMR:
δ 173.6, 136.1, 128.5 (two overlapping signals), 128.2 (two overlapping signals), 93.5, 77.2,
66.1, 49.5, 40.9, 34.3, 31.8, 29.9, 29.4, 29.4, 29.3, 29.2, 29.0, 27.0, 25.7, 24.9, 23.2, 22.7,
14.1; HRFAB-MS (3-NBA matrix): calcd. for C27H43O3Cl2 [M+H]+: 485.2589; found:
485.2572.
First-eluting trans—Rf = 0.28; IR: 3449, 3028, 2920, 2850, 1736, 1456, 1157, 696
cm−1; 1H NMR: δ 7.37-7.32 (5H), 5.12 (s, 2H), 3.99 (ddd, J = 10.0, 8.4, 1.2 Hz, 1H, CH-
OH, trans to the backbone assigned based on 2D-NOESY analysis and 4Jdiagonal H = 1.2
Hz), 2.68-2.64 (m, 1H), 2.52 (d, J = 10.0 Hz, 1H, -OH), 2.34 (t, J = 7.6 Hz, 1H), 2.29-2.20
(m, 1H), 1.67-1.26 (br m, 27H), 0.88 (app t, J = 6.8 Hz, 3H); 13C NMR: δ 173.6, 136.1,
128.5 (two overlapping signals), 128.2 (two overlapping signals), 91.1, 82.6, 66.1, 50.3,
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44.4, 34.3, 31.9, 29.7, 29.5, 29.2, 29.04, 29.02, 28.4, 28.23, 28.15, 27.7, 24.9, 22.7, 14.1;
ESI-MS calcd. for C27H42O3Cl2Na [M+Na]+: 507.2409; found: 507.2422.
Second-eluting cis—Rf = 0.20; IR: 3464, 2924, 2854, 1736,1456, 1169, 696 cm−1; 1H
NMR: δ 7.37-7.32 (m, 5H), 5.11 (s, 2H), 4.55 (dd, J = 10.8, 8.8 Hz, 1H CH-OH, cis to the
backbone assigned based on 2D-NOESY analysis and 4Jdiagonal H = 0), 2.72 (dt, J = 9.2, 5.6
Hz, 1H), 2.65 (d, J = 10.8 H z, 1H, -OH), 2.54 (app dq, J = 9.2, 5.6 Hz, 1H), 2.35 (t, J = 7.2
Hz, 2H), 1.68-1.60 (bm, 3H), 1.52-1.13 (m, 24H), 0.89 (app t, J = 6.8 Hz, 3H); 13C NMR: δ
173.7, 136.1, 128.5 (two overlapping signals), 128.2 (two overlapping signals), 93.5, 77.2,
66.1, 49.5, 40.9, 34.3, 31.8, 29.6, 29.4, 29.2, 29.1, 29.04, 29.00, 27.0, 25.8, 24.8, 23.2, 22.7,
14.1; HRFAB-MS (3-NBA matrix): calcd. for C27H43O3Cl2 [M+H]+: 485.2589; found:
485.2581
Second-eluting trans—Rf = 0.15; IR: 3464, 3033, 2925, 2854, 1738, 1498, 1160, 697
cm−1; 1H NMR: δ 7.37-7.32 (m, 5H), 5.11 (s, 2H), 3.99 (ddd, J = 10.0, 8.4, 1.2 Hz, 1H, CH-
OH, trans to the backbone assigned based on 2D-NOESY analysis and 4Jdiagonal H = 1.2
Hz), 2.69-2.64 (m, 1H), 2.56 (d, J = 10.0 Hz, 1H, -OH), 2.35 (t, J = 7.6 Hz, 2H), 2.26-2.22
(m, 1H), 1.66-1.26 (m, 27H), 0.88 (app t, J = 6.8 Hz, 3H); 13C NMR: δ 173.7, 136.1, 128.5
(two overlapping signals), 128.2 (two overlapping signals), 91.1, 82.6, 66.1, 50.3, 44.3, 34.3,
31.8, 29.7, 29.4, 29.2, 29.04, 28.97, 28.5, 28.21, 28.18, 27.5, 24.8, 22.7, 14.1; HRESI-MS
calcd. for C27H42O3Cl2Na [M+Na]+: 507.2409; found: 507.2426.
The mixture of regioisomeric cyclobutanols converted to the methanesulfonate using a
variant of published procedures.[9,24] Methanesulfonyl chloride (62 mL, 0.80 mmol) was
slowly added to a stirred 0 °C solution of the cyclobutanols (0.193 g, 0.398 mmol) and
triethylamine (0.25 mL, 8.0 mmol) in CH2Cl2 (2 mL) over 15 min. The reaction was
allowed to slowly warm to rt and was stirred for 17 h or until no starting material remained
(TLC). The reaction was diluted with CH2Cl2 (75 mL) and washed sequentially with 1N
HCl (2 × 25 mL), sat aq. NaHCO3 (2 × 25 mL) and water (2 × 25 mL). The organic solution
was then dried with Na2SO4 and concentrated under reduced pressure. The residue was
purified by flash chromatography using 10% EtOAc/Hex to give 20 (0.206 g, 92%) as a
light yellow oil consisting of a 1:1 mixture of regioisomers, each a 92:8 mixture of cis/trans
stereoisomers based upon 1H NMR: Rf (10% EtOAc/Hex) = 0.31 (first trans), 0.26 (first cis/
second trans), 0.21(second cis); IR: 3032, 2925, 2855, 1735, 1458, 1180, 696 cm−1; 1H
NMR: δ 7.36-7.33 (m, 5H), 5.33 (d, J = 9.6 Hz, 0.92H), 5.114/5.109 (two s, total 2H), 4.84
(d, J = 7.6 Hz, 0.08H), 3.208/3.205 (two s, total 3H), 2.76-2.74 (m, 2H), 2.36/2.34 (two
overlapping t, J = 7.6 Hz, total 2H), 1.66-1.60 (m, 4H), 1.46-1.26 (m, 22H), 0.88/0.87
(overlapping t, J = 6.8 Hz, total 3H). Small quantities of individual isomers could be
separated for analysis by HPLC using 10% EtOAc/Hex. The stereochemical assignments
were confirmed by 2D-NMR experiments and by preparation of individual
methanesulfonates from individual stereoisomers of alcohol 19, prepared as described in the
previous step.
First eluting trans—Rf = 0.31; IR: 3032, 2926, 2855, 1737, 1733, 1456, 1180, 697
cm−1; 1H NMR: δ 7.37-7.32 (5H), 5.12 (s, 2H), 4.84 (d, J = 7.6 Hz, 1H), 3.20 (s, 3H),
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2.74-2.68 (m, 2H), 2.36 (t, J = 7.6 Hz, 2H), 1.67-1.32 (br m, 26H), 0.88 (t, J = 6.8 Hz,
3H); 13C NMR: δ 173.6, 136.1, 128.5 (two overlapping signals), 128.2 (two overlapping
signals), 86.4, 85.8, 66.1, 50.5, 41.1, 39.5, 34.3, 31.8, 29.5, 29.4, 29.3, 29.2, 29.01, 28.98,
28.3, 28.1, 27.6, 27.1, 24.9, 22.6, 14.1; HRESI-MS calcd. for C28H44O5Cl2S [M+Na]+:
585.2184; found: 585.2188.
Second-eluting trans—Rf = 0.26; IR: 3040, 2927, 2855, 1734, 1456, 1179, 697 cm−1; 1H
NMR: δ 7.37-7.32 (m, 5H), 5.11 (s, 2H), 4.84 (dd, J = 8.4, 0.8 Hz, 1H), 3.19 (s, 3H),
2.76-2.65 (m, 2H), 2.35 (t, J = 7.6 Hz, 2H), 1.67-1.32 (26H), 0.89 (t, J = 6.8 Hz, 3H); 13C
NMR δ 173.6, 136.1, 128.5 (two overlapping signal), 128.2 (two overlapping signal), 86.4,
85.7, 66.1, 50.5, 41.1, 39.5, 34.3, 31.8, 29.6, 29.31, 29.25, 29.2, 29.0, 28.3, 28.1, 27.6, 27.0,
24.9, 22.7, 14.1: HRESI-MS; calcd. for C28H44O5Cl2S [M+Na]+: 585.2184; found:
585.2205.
First-eluting cis—Rf = 0.26; IR: 2926, 2855, 1736, 1456, 1182, 697 cm−1; 1H NMR: δ
7.37-7.32 (m, 5H), 5.33 (app d, J = 9.6 Hz, 1H), 5.11 (s, 2H), 3.19 (s, 3H), 2.80-2.72 (bm,
2H), 2.36 (app t, J = 7.6 Hz, 2H), 1.70-1.63 (m, 4H), 0.87 (t, J = 6.8 Hz, 3H); 13C NMR: δ
173.6, 136.0, 128.5 (two overlapping signal), 128.1 (two overlapping signal), 88.9, 80.7,
66.0, 49.5, 40.2, 39.2, 34.2, 31.8, 29.7, 29.3, 29.3, 29.2, 29.0, 28.8, 26.7, 25.7, 24.8, 23.7,
22.6, 14.1: HRFAB-MS (3-NBA matrix): calcd. for C28H45O5Cl2S [M+H]+: 563.2365;
found: 563.2349.
Second-eluting cis—Rf = 0.21; IR: 2925, 2855, 1735, 1457, 1181, 697 cm−1; 1H NMR: δ
7.36-7.32 (m, 5H), 5.33 (app d, J = 9.6 Hz, 1H), 5.11 (s, 2H), 3.20 (s, 3H), 2.80-2.69 (bm,
2H), 2.34 (app t, J = 7.6 Hz, 2H), 1.74-1.60 (4H), 1.50-1.19 (22H); 13C NMR: δ 173.6,
136.1, 128.5 (two overlapping signal), 128.1 (two overlapping signal), 89.0, 80.7, 66.0, 49.5,
40.2, 39.3, 34.2, 31.8, 29.5, 29.5, 29.3, 29.2, 28.9, 28.9, 28.7, 26.8, 25.7, 24.8, 23.7, 22.6,
14.1; HRFAB-MS (3-NBA matrix): calcd. for C28H45O5Cl2S [M+H]+: 563.2365; found:
563.2360.
1-(Octanoic acid, 8-yl)-2-octylcyclobutene (5) was prepared from the regioisomeric
mixture of dichloromethanesulfonates 20 using a reported procedure.[9,24] NH3 (~ 15 mL,
liquid) was condensed into a 100 mL three-necked round bottom flask fitted with a dry ice/
acetone condenser. Sodium (0.113 g, 4.90 mmol, sliced under Hex) was added in small
pieces. The resulting deep blue solution was stirred for 20 min. A solution of 0.276 g (0.49
mmol) of 20 in anhydrous THF (1.5 mL) was added over 10 min. The cooling bath was
removed and the reaction was allowed to stir at ~ −35 °C (refluxing NH3) 5–30 min
(depending on the scale of preparation). The reaction was then recooled to −78 °C (dry ice/
acetone) and stirred for 2 h or until the starting material was consumed by TLC. Saturated
aq. NH4Cl was slowly added until the blue color was no longer visible. The condenser was
removed and the reaction mixture was slowly allowed to warm to 0 °C with evaporation of
NH3. The remaining reaction mixture was diluted with 30 mL of water and the suspension
was extracted with CH2Cl2 (3 × 50 mL). The organic layers were combined and washed
sequentially with 1N aq. HCl/water/saturated aq. NaHCO3/water/brine. The organic solution
was then dried with NaSO4, and concentrated under reduced pressure. The residue was
Sittiwong et al. Page 12













purified by flash column chromatography using 10% EtOAc/Hex to afford the cyclobutene
carboxylic acid 5 (0.131 g, 87%) as a low-melting white solid: Rf = 0.50 (80:20:1 of
Hex:EtOAc:AcOH); mp = 33–35 °C; IR: 3493, 3036, 2923, 2853, 1708,1467, 1275, 728
cm−1; 1H NMR: δ 10.94 (br s, 1H, COOH), 6.17-6.15 (br m, 2H), 2.83-2.75 (br s, 2H), 2.35
(t, J = 7.6 Hz, 2H), 1.68-1.60 (br m, 2H), 1.52-1.40 (br m, 2H), 1.35-1.20 (23H), 0.88 (t, J =
6.8 Hz, 3H); 13C NMR (found 18 C) δ 180.6, 140.0, 139.9, 46.8, 46.7, 34.1, 31.9, 29.9, 29.8,
29.8, 29.7, 29.6, 29.5, 29.3, 29.3, 29.2, 29.0, 28.3, 28.2, 24.6, 22.7, 14.1; HRFAB-MS (Gly
matrix) calcd. for C20H35O2 [M-H]−: 307.2637; found: 307.2636. Purity >99 % by HPLC
(retention time, 4.63 min).
cis-9,10-Ethanooctadecanoic acid (6). A solution of cyclobutene 5 (0.031 g, 0.100 mmol)
and 10% Pd/C (0.020 g, 0.020 mmol) in EtOAc (1 mL) was placed in a vial under an
atmosphere of H2 and stirred at rt overnight (16 h). The mixture was then filtered through a
plug of Celite, which was washed with approximately 10 mL of EtOAc. The solution was
then evaporated under vacuum to afford acid 6 (0.030 g, 96%) as a colorless oil which was
sufficiently pure to use without chromatography: Rf = 0.50 (80:20:1 of Hex:EtOAc:AcOH);
IR: 3051 (br), 2921, 2852, 1708 cm−1; 1H NMR: δ 10.93 (br s, 1H, COOH), 2.35 (t, J = 7.3,
2H), 2.24 (br s, 2H), 2.00-1.90 (br m, 1H), 1.64 (quintet J = 7.3 Hz, 2H), 1.60-1.50 (m, 2H),
1.45-1.10 (br m, 24H), 0.88 (br t, J = 7.0 Hz, 3H); 13C NMR: δ 180.2, 37.7, 37.6, 34.1, 31.9,
30.11, 30.05, 29.9, 29.7, 29.7, 29.4, 29.3, 29.1, 27.64, 27.55, 24.8, 24.7, 22.7, 14.1; HRCI-
MS calcd. for C20H38O2 [M+H]+: 311.2950; found: 311.2949. Purity 100% by HPLC
(retention time, 4.56 min).
2-(Octanoic acid benzyl ester, 8-yl) 3-octylcyclobutanone and 3-(Octanoic acid benzyl
ester, 8-yl) 2-octylcyclobutanone (21) was prepared by a modification of a known
procedure.[22–24] To a solution of the regioisomeric dichloroketones 19 (0.670 g, 1.40
mmol) in glacial acetic acid (3 mL) was added Zn(Cu) (0.450 g, 6.90 mmol). The mixture
was stirred at rt under N2 until TLC showed complete disappearance of starting material (~5
h). The reaction mixture was then filtered through a plug of Celite and washed with ether.
The filtrate was washed sequentially with saturated aq. NaHCO3 and water, and dried over
Na2SO4. The residue obtained upon concentration was purified by flash chromatography on
silica gel (5% EtOAc in Hex) to afford (0.388 g, 87%) of a mixture of cyclobutanones 21 as
a colorless oil: Rf = 0.41 (10% EtOAc/Hex); IR: 3034, 2923, 2853, 1774, 1735, 1161, 696
cm−1; 1H NMR: δ 7.36-7.26 (br m, 5H), 5.115 (s, 2H), 3.28-3.17 (br m, 1H), 3.15-3.05 (br
m, 1H), 2.51-2.43 (m, 1H), 2.42-2.32 (br m, 1H), 2.35/2.34 (overlapping t, J = 7.53 Hz, 2H),
1.70-1.50 (br m, 4H), 1.45-1.14 (br m, 22H), 0.88/0.87 (overlapping t, J = 7.19 Hz, 3H); 13C
NMR: δ 212.0, 173.6, 136.1, 128.5, 128.1, 66.0 (br s), 61.9/61.8 (two app s), 50.1/50.1 (two
app s), 34.2, 31.8, 30.1, 30.0, 29.6, 29.6, 29.5, 29.4, 29.4, 29.23, 29.17, 29.0, 28.2, 28.08,
28.05, 27.98, 27.6, 24.9, 24.3, 24.3, 22.6, 14.1; HREI-MS calcd. for C27H41O3Na [M+Na]+:
437.3032; found: 437.3029.
2-(Octanoic acid, 8-yl) 3-octylcyclobutanone and 3-(octanoic acid, 8-yl) 2-
octylcyclobutanone (7). A solution of cyclobutanones 21 (0.039 g, 0.09 mmol) and 10%
Pd/C (0.020 g, 0.18 mmol) in anhydrous MeOH (1 mL) in a vial was placed under an
atmosphere of H2 and stirred at rt overnight (16 h). The mixture was then concentrated
under vacuum. The residue was resuspended in EtOAc (~ 20 mL) and filtered through a plug
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of Celite. The residue obtained upon concentration was purified by flash column
chromatography on silica gel (10%/25% EtOAc/Hex) to afford the regioisomeric mixture of
carboxylic acids 7 (0.027 g, 87%) as a colorless oil: Rf = 0.16 (25% EtOAc/Hex); IR: 3322
(br), 2926, 2856, 1776, 1709, 913, 749 cm−1; 1H NMR: δ 3.28-3.18 (br m, 1H), 3.13/3.09
(overlapping dd, J = 9.6, 3.1 and 9.0, 3.5, 0.56H/0.44H), 2.50/2.46 (two app abnormal-shape
quintets, 0.55H/0.52H), 2.42 (br dd, J = 9.6, 4.5 Hz, 1H), 2.35/2.34 (two app t, J = 7.45 Hz,
2H), 1.63-1.54 (br m, 4H), 1.43-1.18 (br m, 22H), 0.88/0.87 (overlapping br t, J = 7.0 Hz,
3H); 13C NMR: δ 212.1, 179.9, 62.0/61.9 (two app s), 50.20/50.17 (two app s), 34.0, 31.9,
30.1, 30.1, 29.7, 29.6, 29.6, 29.4, 29.3, 29.2, 29.02, 28.98, 28.2, 28.1, 28.0, 27.6, 24.6, 24.3,
24.3, 22.7, 14.1; HREI-MS calcd. for C20H36O3Na [M+Na]+: 347.2557; found: 347.2557.
Purity >97% by HPLC (retention time, 6.82 min).
2-(Octanoic acid, 8-yl) 3-octylcyclobutanol and 3-(Octanoic acid, 8-yl) 2-
octylcyclobutanol (8). To a −10 °C (ice/NaCl bath) solution of the cyclobutanone 21 (0.037
g, 0.070 mmol) in anhydrous MeOH (1.5 mL) was added NaBH4 (0.005 g, 0.150 mmol)
under N2. The reaction mixture was stirred at −10 °C until no starting material remained on
TLC (~ 20 min). The reaction was diluted with CH2Cl2 (about 5 mL) and quenched with sat.
NaHCO3 (2 mL). The mixture was stirred for 10 min. The organic layer was removed and
the aqueous layer was extracted with CH2Cl2 (3 × 5 mL). The organic layers were
combined, dried over with Na2SO4, and evaporated to afford the alcohol as a colorless oil
(0.029 g, 99%). Although the crude product appears pure by 1H NMR, it is actually a
mixture of two regioisomers, each a 70:30 mixture of the 1,2,3- cis/cis and the 1,2-trans-2,3-
cis isomers (identities established through 2D-NMR). The individual isomers can be
detected by TLC in 20% EtOAc/Hex: Rf = 0.50 (major, all cis), 0.45 (major, all cis), 0.39
(minor, OH is trans to backbone), and 0.37 (minor, OH is trans to backbone); IR: 3396 (br),
2922, 2852, 1737, 1156, 732, 696 cm−1; 1H NMR: δ 7.39-7.28 (br m, 5H), 5.14 (s, 2H), 4.23
br q, J = 7.3, 0.7H), 3.93 (br q, J = 7.3, 0.3H), 2.42-2.36 (overlapping signal, 1H), 2.37 (t, J
= 7.6, 2H), 2.15-1.95 (br m, 1H), 1.90-1.78 (br m, 1H,), 1.70-1.60 (br m, 2H), 1.60-1.48 br
m, 2H), 1.45-1.20 (br m, 22H), 0.90 (br t, J = 7.6, 2H); 13C NMR: δ 173.68/173.65
(overlapping), 136.1, 128.5, 128.1, 72.2, 66.09/66.06 (two overlapping s), 66.0, 43.97/43.95
(overlapping), 37.3, 34.3, 31.9, 30.7, 30.6, 30.2, 29.94, 29.87, 29.8, 29.7, 29.62, 29.58, 29.5,
29.33, 29.29, 29.2, 29.14, 29.08, 29.0, 27.7, 27.6, 24.90, 24.88, 23.4, 23.3, 22.7, 14.1;
HRESI-MS calcd. for C27H44O3Na [M+Na]+: 439.3188; found: 439.3174.
Using a procedure similar to that described for preparation of 6, the cyclobutanol benzyl
esters (0.025 g, 0.060 mmol were subjected to hydrogenation in the presence of 10% Pd/C
(0.013 g, 0.012 mmol) and EtOAc (0.6 mL) to afford cyclobutanol acid 8 (0.016 g, 81%) as
a colorless oil. Although the product is assumed to consist of a similar mixture of regio- and
stereoisomers as was present in the benzyl ester precursor, the individual isomers are not
separable: Rf = 0.32 (4:6:0.05 of EtOAc:Hex:AcOH); IR: 3309 (br), 2922, 2853, 1709
cm−1; 1H NMR: δ 4.22 (q, J = 7.6, 0.7H, assumed -OH is cis to backbone from the
characterization of starting material), 3.92 (q, J = 7.6, 0.3H, assumed OH is trans to
backbone), 2.43-2.33 (br m, 1H), 2.34 (t, J = 7.3, 2H), 2.18-1.92 (m), 1.84 (br septet, J =
8.0, 1H), 1.68-1.58 (br quintet, J = 7.0, 2H), 1.58-1.48 (br m, 2H), 1.43-1.18 (br m, 22H),
0.88 (br t, J = 7.0 Hz, 3H); 13C NMR: δ 179.50/179.46 (two app s), 72.28, 66.16/66.12 (two
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app s), 48.87/48.79 (two app s), 43.97, 37.26, 35.06, 33.98, 31.89, 30.69/30.62, 30.24,
30.18, 29.90, 29.87, 29.79, 29.74, 29.63, 29.60, 29.51, 29.46, 29.34, 29.31, 29.21, 29.11,
29.06, 29.01, 28.99, 28.97, 28.67, 28.60, 28.05, 27.95, 27.92, 27.73, 27.60, 24.66/24.63,
23.38/23.34, 22.67, 14.10; HRESI-MS calcd. for C20H38O3Na [M+Na]+: 349.2719; Found
349.2715. Purity >99 % by HPLC (retention time, 11.8 and 15.9 min).
2-Chloro-4-(octanoic acid benzyl ester, 8-yl)-3-octylcyclobutanone; 2-Chloro-3-
(octanoic acid benzyl ester, 8-yl) 4-octylcyclobutanone (22) was prepared based on a
modification of a known procedure.[9,22,24] To a solution of dichloroketone 19 (0.992 g,
2.100 mmol) in 4 mL of glacial acetic acid was added Zn dust (0.148 g, 2.30 mmol). [Note:
The amount of Zn required depended upon the purity of the dichlorocyclobutanone. and it
was generally necessary to add a second equivalent after approximately 12 h of reaction.]
The mixture was stirred at rt until complete disappearance of the starting material was
observed (16 h, TLC). The reaction mixture was then cooled in an ice bath and diluted with
water (20 mL). The resulting solution was extracted with EtOAc (3 × 50 mL) and the
combined organic layers were washed sequentially with water (2 × 100 mL) and saturated
NaHCO3 solution (2 × 50 mL). The resulting organic layer was dried over Na2SO4 and
concentrated under reduced pressure to furnish a colorless oil (0.895 g, 97% crude yield) as
a 1:1 mixture of regioisomers, each a 9:1 mixture of cis/trans stereoisomers (1H NMR); the
mixture was used directly in the next step. Analysis of the 1H NMR indicated that the
expected product was accompanied by recovered starting material 19 (approximately 14%)
and the cyclobutanone 21 (overreduction product, approximately 10%). These byproducts
could not be removed easily by flash chromatography. Rf = 0.58/0.53 (major), 0.48/0.43
(minor) (10% EtOAc in Hex); IR: 3036, 2925, 2854, 1789, 1735, 1456, 1162, 696 cm−1; 1H
NMR: δ 7.36-7.25 (m, 5H), 5.12/5.11 (overlapping s, 2H), 4.97 (dd, J = 2.6, 9.5, 0.1H), 4.51
(dd, J = 2.8, 7.6 Hz, 0.9H), 3.35-3.20 (m, 1.1H), 2.75-2.65 (m, 0.1H), 2.53-2.40 (m, 0.9H),
2.36/2.35 (overlapping t, J = 7.2 Hz, 2H), 1.75-1.20 (m, 26H), 0.92-0.85 (m, 3H); 13C NMR:
δ 203.48/203.45, 173.5, 136.1, 128.5, 128.1, 66.0, 65.7, 58.3, 58.2, 40.74/40.72, 34.18,
31.77/31.75, 29.5, 29.3, 29.24, 29.16, 29.14, 29.13, 29.02, 28.97, 28.90, 28.86, 28.02, 27.96,
27.92, 27.87, 25.64/25.57, 24.80/24.78, 22.59/22.58, 14.0; HRESI-MS calcd. for
C27H41O3ClNa [M+Na]+: 471.2642; found 471.2635.
2-Chloro-4-(octanoic acid, 8-yl) 3-octylcyclobutanone-; 2-Chloro-3-(octanoic acid, 8-yl)
4-octylcyclobutanone (9) was prepared in a similar manner as compound 6 from reaction of
benzyl ester 22 (0.085 g, 0.19 mmol), 10% Pd/C (0.040 g, 0.038 mmol) and EtOAc (1.9
mL). The product, acid 9 (0.048 g, 70%), was obtained as a colorless oil after purification by
flash column chromatography (20% EtOAc/Hex). The product, which was predominantly
the cis,cis-stereoisomer on the cyclobutanone, included approximately 5% of an inseparable
trans-chlorocyclobutanone 11 (1H NMR signal at δ 4.37) probably arising from the
epimerization of 9: Rf = 0.19 (4:1 Hex:EtOAc); IR: 3036, 2924, 2854, 1788, 1706, 1461
cm−1; 1H NMR: δ 10.74 (br s, 1H, COOH), 4.96 (dd, J = 9.4, 2.6, 0.05H), 4.50 (dd, J = 7.6,
2.8, 0.95H), 3.35-3.20 (m, 1.05H), 2.46 (quintet, J = 8.1, 0.95H), 2.74-2.62 (m, 0.05H),
2.35/2.33 (overlapping t, J = 7.3, 2H), 1.80-1.15 (m, 22H), 0.88/0.87 (overlapping t, J = 6.9,
3H); 13C NMR: δ 203.62/203.56, 180.1, 65.7, 58.30/58.26, 401.8, 34.0, 31.8, 29.5, 29.4,
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29.3, 29.18/29.15, 29.04/29.00, 28.9, 28.04/27.98, 27.95/27.90, 25.67/25.59, 24.5, 22.6,
14.1; HRESI-MS calcd. for C20H35O3ClNa [M+Na]+: 381.2172; found 381.2191.
2,2-Dichloro-4-(octanoic acid benzyl ester, 8-yl) 3-octylcyclobutanone-; 2,2-Dichloro-3-
(octanoic acid benzyl ester, 8-yl) 4-octylcyclobutanone (23) was prepared based on a
known procedure.[22–24] To a mixture of Zn(Cu) (1.84 g, 28.0 mmol) and benzyl elaidate
(2.07 g, 5.60 mmol) in 11 mL of anhydrous ether was added over 2 h (syringe pump)
trichloroacetyl chloride (2.0 mL, 18 mmol). The reaction mixture was stirred at rt for 5 h (or
until the starting material is consumed by TLC) and filtered through a plug of Celite. The
residue was washed with ether (20 mL). The combined ether layers were transferred to a
round bottom flask and cooled over ice. The black solution was then diluted with 40 mL of
water and 40 mL of sat. NaHCO3. The mixture was allowed to warm to rt and stirred
overnight. The aqueous layer was extracted with ether (3 × 50 mL) and the combined
organic layers were dried over Na2SO4 and evaporated to dryness. The residue obtained
upon concentration could be used for the next step without further purification or,
alternatively, could be purified by rapid flash column chromatography through a short plug
of silica (2.5%/5% EtOAc/Hex) to afford a yellow oil (1.69 g, 63%) consisting of a 1:1
mixture of regioisomers: Rf = 0.63 (20% EtOAc/Hex); IR: 2926, 2855, 1802, 1735, 1456,
1162, 696 cm−1; 1H NMR: δ 7.47-7.23 (m, 5H), 5.120/5.117 (overlapping s, 2H),
3.158/3.126 (overlapping dt, J = 7.2, 1.5 Hz, 1H), 2.56-2.46 (m, 1H), 2.37/2.34 (overlapping
t, J = 7.6 Hz, 2H), 1.96-1.18 (m, 26H), 0.90/0.87 (overlapping t, J = 7.2 Hz, 3H); 13C NMR,
75 MHz : δ 196.3, 173.5, 136.0, 128.4, 128.1, 87.1, 66.0, 60.7, 60.6, 52.3, 34.2, 34.1, 31.8,
31.7, 31.37, 31.36, 29.42, 29.40, 29.3, 29.23, 29.20, 29.14, 29.12, 29.08, 28.93, 28.90,
28.85, 27.5, 27.4, 27.12, 27.05, 24.80, 24.78, 22.59, 22.57, 14.04, 14.03; HRESI-MS calcd.
for C27H40O3Cl2Na [M+Na]+: 505.2252; found: 505.2248.
2,2-Dichloro-4-(octanoic acid benzyl ester, 8-yl) 3-octylcyclobutanol, methanesulfonate
ester; 2,2-Dichloro-3-(octanoic acid benzyl ester, 8-yl) 4-octylcyclobutanol,
methanesulfonate ester (24) was prepared by a similar procedure as 20 through reaction of
dichlorocyclobutanone 23 (0.210 g, 0.400 mmol), NaBH4 (0.055 g, 1.50 mmol), and iPrOH
6 mL. The 1:1 mixture of regioisomeric dichlorocyclobutanols (0.166 g, 85%) was obtained
as a colorless oil following flash chromatography (5% EtOAc/Hex): Rf = 0.66(minor)/
0.61(major)/0.56(minor)/0.51(major) (10% EtOAc/Hex). IR: 3459 (br), 2924, 2853, 1736,
1456, 1161, 734, 696 cm−1; 1H NMR: δ 7.36-7.31 (m, 5H), 5.12 (s, 2H), 4.37 (br d, J = 6.4
Hz, 0.4H), 3.91 (br d, J = 8.0 Hz, 0.6H), 2.80-2.45 (br m, 2H), 2.37/2.36 (overlapping t, J =
7.6 Hz, 2H), 1.80-1.05 (br m, 26H), 0.89/0.88 (overlapping t, J = 6.7 Hz, 3H). Small
quantities of individual isomers could be separated for analysis by flash column
chromatography using 10% EtOAc/Hex. Stereochemical assignments are based upon 2D-
NMR experiments (COSY, NOESY, and HSQC).
First-eluting H1-H3 trans—Rf =0.66; IR: 3463 (br), 2927, 2855, 1738, 1453, 1158
cm−1; 1H NMR: δ 7.37-7.31 (m, 5H), 5.12 (s, 2H), 4.38 (ddd, 3JH1,H4 = 6.8 Hz, 3JH1,OH =
5.1 Hz, 4JH1,H3(trans) = 1.3 Hz, 1H, CH-OH), 2.62-2.55 (m, 1H, CH-CCl2), 2.44 (d, 3JH1,OH
= 5.1 Hz, -OH), 2.36 (t, J = 7.6 Hz, 2H), 2.18-2.08 (m, 1H, CH-CHOH), 1.80-1.10 (br m,
26H), 0.89 (t, J = 6.7 Hz, 3H); 13C NMR (NOESY): δ 173.6, 136.1, 128.5, 128.2, 90.2, 78.5,
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66.1, 57.0, 42.0, 34.3, 31.9, 31.3, 29.7, 29.5, 29.4, 29.3, 29.0, 27.7, 27.5, 26.6, 24.9, 22.7,
14.1; HRESI-MS calcd. for C27H40O3Cl2 [M+Na]+: 507.2409; found: 507.2409.
First-eluting H1-H3 cis—Rf =0.61; IR: 3448 (br), 2925, 2854, 1737, 1456, 1163, 734, 697
cm−1; 1H NMR: δ 7.37-7.31 (m, 5H), 5.12 (s, 2H), 3.91 (dd, 3JH1,OH = 10.8
Hz, 3JH1,H4(trans) = 8.0 Hz, 4JH1,H3(cis) = 0 Hz, 1H, CH-OH), 2.46 (d, J = 10.8 Hz, 2H, OH),
2.36 (t, J = 7.6 Hz, 2H), 2.11-2.04 (m, 1H, CH-CCl2), 1.75-1.18 (m, 27H), 0.88 (t, J = 6.8
Hz, 3H); 13C NMR, 75 MHz (NOESY): δ 173.6, 136.1, 128.5, 128.2, 91.0, 81.6, 66.1, 51.9,
48.1, 34.3, 33.0, 31.8, 30.0, 29.6, 29.41, 29.38, 29.2, 29.0, 27.3, 26.8, 24.9, 22.6, 14.1;
HRESI-MS calcd. for C27H40O3Cl2 [M+Na]+: 507.2409; found: 507.2415.
Second-eluting H1-H3 trans—Rf = 0.56; IR: 3463 (br), 2925, 2854, 1736, 1456, 1163,
696 cm−1; 1H NMR: δ 7.36-7.31 (m, 5H), 5.11 (s, 2H), 4.40-4.34 (m, 1H), 2.64-2.55 (m, 1H,
CH-OH), 2.64-2.55 (m, 1H, CH-CCl2), 2.46 (d, J = 4.8 Hz, 1H, OH), 2.35 (t, J = 7.6 Hz,
2H), 2.20-2.03 (m, 1H, CH-CHOH), 1.80-1.10 (br m, 26H), 0.88 (t, J = 6.4 Hz, 3H); 13C
NMR, 75 MHz: δ 173.7, 136.1, 128.5, 128.2, 90.2, 78.4, 66.1, 57.0, 42.0, 34.3, 31.9, 31.3,
29.6, 29.5, 29.41, 29.39, 29.2, 29.1, 29.0, 27.6, 27.5, 26.7, 24.9, 22.7, 14.1; HRESI-MS
calcd. for C27H40O3Cl2 [M+Na]+: 507.2409; found: 507.2398.
Second-eluting H1-H3 cis—Rf = 0.51; IR: 3444 (br), 2924, 2854, 1734, 1162, 734, 696
cm−1; 1H NMR: δ 7.37-7.31 (m, 5H), 5.11 (s, 2H), 3.90 (dd, 3JH1,OH = 10.8
Hz, 3JH1,H4(trans) = 8.0 Hz, 4JH1,H3(cis) = 0 Hz, 1H, CH-OH), 2.52 (OH, d, J = 10.8 Hz, 2H),
2.35 (t, J = 7.6 Hz, 2H), 2.13-2.02 (m, 1H, CH-CCl2), 1.75-1.18 (m, 27H), 0.89 (t, J = 6.8
Hz, 3H); 13C NMR: (75 MHz): δ 173.7, 136.1, 128.5, 128.1, 91.0, 81.6, 66.1, 51.9, 48.0,
34.2, 33.0, 31.8, 30.0, 29.6, 29.4, 29.3, 29.2, 29.02, 28.97, 28.9, 27.2, 26.8, 24.9, 24.8, 22.6,
14.1; HRESI-MS calcd. for C27H40O3Cl2: [M+Na]+ 507.2409; found:507.2409.
The mixture of dichlorocyclobutanols was converted to the methanesulfonates (mesylate) in
a similar manner as for 20. Reaction of methanesulfonyl chloride (0.05 mL, 0.70 mmol), the
dichlorocyclobutanols (0.166 g, 0.300 mmol), and triethylamine (0.20 mL, 1.7 mmol) in
CH2Cl2 (2 mL), followed by purification using flash chromatography (5% EtOAc/Hex)
provided dichloromesylate 24 as a light yellow oil (0.146 g, 86 %) as a mixture of
inseparable region- and stereoisomers: Rf = 0.40/0.38 (20% EtOAc/Hex); IR: 2925, 2851,
1734, 1368, 1180, 964, 697 cm−1; 1H NMR: δ 7.38-7.30 (m, 5H), 5.20 (dd, J = 7.1, 1.2 Hz,
0.4H), 5.115/5.112 (two overlapping s, total 2H), 4.84 (d, J = 8.8 Hz, 0.6H), 3.202/3.199
(two overlapping s, 1.8H), 3.166/3.163 (two overlapping s, total 1.2H), 2.66-2.58 (m, 0.4H),
2.40-2.30 (m, 2H), 2.21-2.12 (m, 0.6H), 2.10-1.98 (m 0.6H), 1.80-1.15 (m, 26.4H),
0.91-0.86 (m, 3H); 13C NMR: 173.6, 136.10/136.08, 128.5/128.1, 86.45/86.38, 84.09,
83.86/83.82, 66.03/66.01, 57.18, 51.81/51.80, 44.51/44.50, 41.71, 39.5, 39.0, 34.2,
32.21/32.18, 31.78/31.77, 31.41/31.36, 30.1, 29.49 29.46, 29.42, 29.34, 29.32, 29.27, 29.22,
29.16, 28.95, 28.90, 28.2, 27.0, 26.9, 26.8, 26.7, 26.6, 26.5, 26.4, 26.3, 24.8, 22.6, 14.1;
HRESI-MS C28H44O5Cl2SNa [M+Na]+: 585.2184; found: 585.2186.
1-(Octanoic acid, 8-yl)-2-octylcyclobutene (10) was prepared from reductive
fragmentation and deprotection of dichloromethansulfonate 24 (0.143 g, 0.250 mmol) in
THF (1 mL), NH3 (~ 10 mL) and Na (~ 0.090 g, 4.10 mmol) by a procedure similar to that
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employed for 5. The crude product was purified by flash chromatography (10% EtOAc/Hex)
to afford the acid 10 (0.035 g, 46%) as a colorless oil: Rf = 0.35 (60:40 of Hex:EtOAc); IR:
3124, 2923, 2852, 1708, 910, 736 cm−1; 1H NMR: δ 6.12 (br s, 2H), 2.35 (t, J = 7.2 Hz, 2H),
2.26 (t, J = 7.2 Hz, 2H), 1.64 (quintet, J = 7.2 Hz, 2H), 1.44 (br m, 4H), 1.35-1.20 (23H),
0.88 (t, J = 6.8 Hz, 3H); 13C NMR: δ 179.7, 139.2, 139.1, 50.4, 50.3, 34.02, 33.97, 31.9,
29.9, 29.6, 29.3, 29.2, 29.0, 28.4, 28.3, 24.7, 22.7, 14.1; HRFAB-MS (3-NBA matrix):
calcd. for C20H35O2Li2 [M-H+2Li]+: 321.2957; found: 321.2969. Purity 100% by HPLC
(retention time, 4.73 min).
2-Chloro-4-(octanoic acid, 8-yl) 3-octylcyclobutanone-; 2-Chloro-3-(octanoic acid, 8-yl)
4-octylcyclobutanone (11) was prepared by a similar procedure as described for compound
9. Reaction of benzyl ester 23 (0.500 g, 1.000 mmol), Zn(Cu) (0.074 g, 1.10 mmol) and
glacial acetic acid (2 mL) furnished, after flash chromatography (5% EtOAc/Hex), trans-
monochlorocyclobutanone (0.313 g, 70%) as a colorless oil which included an equal mix of
the 2-chloro-4-octyl and 2-chloro-3-octyl regioisomers, each of which included both epimers
at the chloride-bearing carbon: Rf = 0.42/0.39 (minor) and 0.33 (major) (10% EtOAc/Hex).
The amount of Zn dust varied from 1.1–2.2 equivalents; generally, a second equivalent of
zinc dust was added to the incomplete reaction mixture after stirring for approximately 12 h.
The residual dichlorocyclobutanone was easily removed by flash column chromatography.
However, the cyclobutanone product of overreduction was formed in significant amounts
(28% based upon 1H NMR and was nearly inseparable by flash column chromatography: IR:
2924, 2854, 1788, 1735, 1457, 1161, 733, 696 cm−1; 1H NMR: δ 7.40-7.32 (m, 5H),
5.113/5.110 (overlapping s, 2H), 4.95 (dd, J = 3.1, 9.4, 0.3H), 4.37 (dt, J = 2.7, 7.8 Hz,
0.7H), 2.97-2.90 (m, 0.3H), 2.84-2.74 (m, 0.7H), 2.40-2.30 (overlapping m, 2.3H), 2.08-1.97
(m, 0.7H), 1.85-1.10 (m, 26H), 0.92-0.84 (m, 3H); 13C NMR: δ 204.6, 202.0, 173.5, 136.1,
128.5, 128.1, 66.0, 65.52/65.46, 63.98, 63.78/63.75, 63.57/63.52, 60.74/60.69, 49.8, 43.7,
37.4, 36.63/36.59, 35.12/35.10, 34.2, 31.8, 31.3, 30.3, 30.1, 29.5, 29.42, 29.38,29.32, 29.25,
29.19, 29.03, 29.00, 28.96, 28.93, 28.88, 28.2, 27.67, 27.60, 27.55, 27.48, 27.38, 27.3, 27.2,
27.1, 24.83/24.80, 22.6, 14.0; HRESI-MS calcd. for C27H41O3ClNa [M+Na]+: 471.2642;
found: 471.2630.
The resulting mixture of monochloroketone mixtures was subjected to debenzylation
described in the preparation of compound 6. Reaction of the benzyl ester mixture (0.034 g,
0.11 mmol), with 10% Pd/C (0.024 g, 0.022 mmol) and EtOAc (1 mL) afforded the
unprotected acid (0.013 g, 54%) as a white solid: Rf = 0.24 (6:4:0.05 of Hex:EtOAc:AcOH);
mp = 74–75 °C; IR: 3062, 2924, 2854, 1789, 1708, 1464 cm−1; 1H NMR: δ 8.70 (br s, 1H),
4.95 (dd, J = 2.9, 9.2, 0.3H), 4.37 (ddd, J = 7.8, 2.5, 1.3, 0.7H), 2.97-2.91 (m, 0.3H),
2.85-2.73 (m, 0.7H), 2.40-2.22 (m, 22H), 2.11-2.98 (m 0.7H), 1.85-1.10 (m 26H), 0.92-0.82
(m, 3H); 13C NMR δ 211.7, 204.7, 202.2, 179.9, 65.6/65.5, 64.0, 63.85/63.82, 63.64/63.58,
60.82/60.77, 49.81, 43.8, 37.5, 36.69/36.65, 35.2, 34.0, 31.8, 31.3, 30.4, 30.2, 29.55, 29.48,
29.44, 29.38, 29.31, 29.25, 29.2, 29.06, 29.06, 28.9, 28.3, 28.2, 27.73, 27.67, 27.62, 27.44,
27.37, 27.26, 27.20, 27.17, 24.63/24.60, 22.7, 14.1; HRESI-MS calcd. for C20H35O3ClNa
[M+Na]+: 381.2172; found: 381.2170.
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Determination of inhibitor aqueous stability and solubility
One-dimensional (1D) 1H-NMR spectroscopy was used to verify the chemical purity,
aqueous stability, and concentration dependent micelle formation of eleven fatty acid
analogs. Each compound was dissolved in deuterated dimethyl sulfoxide (DMSO-d6) to
obtain a stock concentration of 20 mM. Six different concentrations were prepared from the
stock solutions for NMR analysis: 1.00 mM, 750 μM, 500 μM, 100 μM, and 0 μM. All NMR
samples consisted of 600 μL of a deuterated 50 mM potassium phosphate buffer at pH 7.2
with 50 μM of 3 (trimethylsilyl) propionic-2,2,3,3-d4 acid sodium salt (TMSP). Each 600 μL
NMR sample contains 30 μL (5%) of DMSO-d6 and was transferred to a 5 mm NMR tube
for analysis.
A Bruker Avance DRX 500-MHz spectrometer equipped with a 5 mm triple-resonance
cryoprobe (1H, 13C, 15N) with a z-axis gradient was utilized for all 1D 1H NMR
experiments. Acquisition of NMR spectra was automated using a BACS-120 sample
changer and Icon NMR software. All spectra were acquired at 298.15 K with 16 dummy
scans, 64 scans, 32K data points, a spectral width of 5482.46 Hz, and a relaxation delay of
1.5 s. The NMR spectra were processed and analyzed using ACD/1D NMR Manager
(Advanced Chemistry Development). The resulting 1D 1H NMR spectra were visually
inspected for evidence of micelle formation (peak broadening), or chemical instability/
impurities (additional peaks).
Measurement of nonspecific cytotoxicity
RAW 264.7 macrophages were incubated with 0–100 mM of oleic acid or the C18
cyclobutene fatty acid 2, each delivered as bovine serum albumin complexes. After 24 h,
cell viability was relative to untreated controls was assessed using an IN CTYOTOX-CVDE
Crystal violet Dye Elution Kit. The values shown in Figure 2 are means ± SEM based upon
measurement in triplicate.
Bacterial strains and culture conditions
Bacterial strains used in this study are the E. coli wild type strain G58-1, the genome
sequencing Msm strain mc2155, and the Mtb strains CDC 1551 and H37Rv. Cells were
grown shaking at 37 °C in LB broth for E. coli or complete Middlebrook 7H9 broth
supplemented with 0.05% v/v Tween 80 to an O.D.600 of 0.6–1.2 for mycobacteria. For MIC
determinations, cells were inoculated into LB for E. coli or a modified previously reported
minimal medium for both E. coli and mycobacteria.[26] The minimal media components and
final concentrations are as follows: 22 mM dibasic potassium phosphate, 16 mM monobasic
potassium phosphate, 2.8 × 10−5 mM ferric chloride, 8.7 × 10−3 mM zinc sulfate, 8.4 × 10−4
mM cobalt(II) chloride, 1.0 × 10−2 mM manganese chloride, 6.8 × 10−2 mM calcium
chloride, 2.4 mM magnesium sulfate, 5.0 mM ammonium chloride, 25 mM glycerol, and
0.02% v/v Tyloxapol.
Drug susceptibility assays
MICs were determined by a 96-well microplate method, as described by Chacon.[26]
Bacteria were harvested, washed 2× with minimal media, and inoculated to an initial
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concentration of approximately 1.0 × 105 colony forming units (CFU) per well. The initial
inoculum was plated to verify retrospectively the desired CFU/ml for each strain. Stocks of
fatty acid analog compounds were prepared in 100% DMSO-d6, as this solvent was chosen
to provide consistency with the NMR studies. Appropriate doubling dilution gradients
(μg/mL of compound dissolved in the corresponding % v/v DMSO- d6) were prepared in the
following ranges for each compound tested: E. coli, 8 to 512; Msm, 16 to 1024; and Mtb,
0.25 to 256 (e.g., 64 μg/mL of compound corresponded to 0.064% v/v of DMSO-d6).
Alternatively, the concentration of DMSO-d6 was adjusted in all wells to its maximum
concentration in the corresponding gradient (e.g., 64 μg/ml of compound corresponded to
0.256% v/v of DMSO-d6). We tested cells in the absence of compound and DMSO-d6 to
verify cell viability. The effect of DMSO-d6 was also tested by growing cells in minimal
media with DMSO-d6 and no compound. We observed no significant effect of DMSO-d6 on
cell viability for E. coli and Msm. However for Mtb, we observed some variability with
anomalous inhibitory results in a few technical replicate wells containing DMSO-d6 alone at
higher concentrations. Nonetheless, most of the replicate wells displayed no inhibition
allowing us to eliminate these anomalous results. Moreover, the effect of the compound was
observed at DMSO-d6 concentrations having no inhibitory action. Plates were incubated at
37 °C for 2 days (E. coli), 4 days (Msm) or 7 weeks (Mtb). MIC values were determined by
the consistent results of three biological and three technical replicates. The MIC was defined
by taking the mode of three independent cultures where the MIC did not differ by more than
one doubling dilution, discarding any results that are two doubling dilutions away from the
mode.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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HPLC High-performance liquid chromatography
HRESI High resolution mass spectrometry via electrospray ionization
HRFAB High resolution mass spectrometry via fast atom bombardment




MIC Minimum inhibitory concentration
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NOESY Nuclear Overhauser effect spectroscopy
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Analogs investigated, along with structures of oleic (cis-18:1), elaidic (trans-18:1) and
decenoic (10:1) acids. R = octyl.
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1D 1H NMR spectra of compounds 5 (Figure 2a) and 1 (Figure 2b) were inspected for
evidence of micelle formation (peak broadening) by comparing peak widths relative to
TMSP (standard). Peak widths for 5 demonstrated potential micelle formation or
aggregation over the range of tested concentrations (highlighted region). No micelle
formation was observed for compounds 1–4 between 100 – 1000 μM.
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Preparation of analogs in the C10 series (1–4): a) DMAP, DCC, BnOH; b) Zn dust (5 equiv),
Cl3CCOCl (2.5 equiv) rt, Et2O; c) NaBH4, 2-propanol; d) MsCl, Et3N; e) Na/NH3, −78 to
−33 °C; f) H2, Pd/C; g) Zn (5 equiv), AcOH; h) NaBH4, MeOH.
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Synthesis of analogs 5–9: a) DMAP, DCC, BnOH; b) Zn dust (5 equiv), Cl3CCOCl (2.5
equiv), ether; c) NaBH4, 2-propanol; d) MsCl, Et3N; e) Na/NH3, −78 to −33 °C; f) H2, Pd/C
EtOAc; g) Zn (5 equiv), AcOH; h) NaBH4, MeOH, −10 °C; i) Zn (1.1 equiv), AcOH. R =
octyl.
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Synthesis of analogs 10 and 11: a) DMAP, DCC, BnOH; b) Zn(Cu) (5 equiv), Cl3CCOCl
(2.5 equiv), rt, ether; c) NaBH4, 2-propanol; d) MsCl, Et3N; e) Na/NH3, −78 to −33 °C; f)
Zn (1.1 equiv), AcOH; g) H2, Pd/C EtOAc.
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Table 1
Critical micellar coefficient (CMC) of analogs under assay conditionsa
CMC ≤ 100 μM ≥ 1000 μM
Analogs 5–11 1–4
a
Designated concentration or range indicates onset of aggregation observed by 1H NMR of buffer solutions; see Experimental Section.

















































































































































































































































































































































































































































































































ChemMedChem. Author manuscript; available in PMC 2015 August 01.
Supporting Information
 Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2014
Development of Cyclobutene- and Cyclobutane-
Functionalized Fatty Acids with Inhibitory Activity against
Mycobacterium tuberculosis
Wantanee Sittiwong,[a] Denise K. Zinniel,[b] Robert J. Fenton,[b] Darrell D. Marshall,[a]




Description of Material page numbers 
Synthesis of known benzyl esters 2-3 
Cytotoxicity data 4 
Thermal stability data 5-10 
Investigation of aggregation in aqueous buffer. Stacked 1H NMR plots for  
decenoic acid (12), oleic acid (13), and analogs 2, 4, 5, and 7-11.  11-20 
References for experimental materials 21 
1H-NMR and 13C-NMR spectrum of 9-decenoic acid, benzyl ester 22 
1H-NMR and 13C-NMR spectrum of 15 23 
1H-NMR and 13C-NMR spectrum of dichlorocyclobutanols (C10 series) 24 
1H-NMR and 13C-NMR spectrum of 16 25  
1H-NMR and 13C-NMR spectrum of 1 26  
1H-NMR and 13C-NMR spectrum of 2 27  
1H-NMR and 13C-NMR spectrum of 17 28  
1H-NMR and 13C-NMR spectrum of 3 29  
1H-NMR and 13C-NMR spectrum of 18 30 
1H-NMR and 13C-NMR spectrum of 4 31   
1H-NMR and 13C-NMR spectrum of 19 (mixture and individual isomers) 32-37   
1H-NMR and 13C-NMR spectrum of 20 (mixture and individual isomers) 38-42  
1H-NMR and 13C-NMR spectrum of 5 43    
1H-NMR and 13C-NMR spectrum of 6  44  
1H-NMR and 13C-NMR spectrum of 21 45  
1H-NMR and 13C-NMR spectrum of 7 46 
1H-NMR and 13C-NMR spectrum of cis-18:1 cyclobutanols (benzyl esters) 47 
1H-NMR and 13C-NMR spectrum of 8 48  
1H-NMR and 13C-NMR spectrum of 22 49  
1H-NMR and 13C-NMR spectrum of 9  50 
1H-NMR and 13C-NMR spectrum of benzyl elaidate 51  
1H-NMR and 13C-NMR spectrum of 23  52 
1H-NMR and 13C-NMR spectrum of dichlorocyclobutanols (trans 18:1 series) 53-57 
1H-NMR and 13C-NMR spectrum of 24  58  
1H-NMR and 13C-NMR spectrum of 10 59 
1H-NMR and 13C-NMR spectrum of chloroketones (benzyl ester)  60 




Benzyl 9-decenoate was prepared by a known procedure.1 Thionyl chloride (36.9 mL, 51 
mmol) was added to a stirred solution of 9-decenoic acid DA (8.67 g, 51 mmol) and catalytic 
dimethylformamide (DMF, 0.12 mL, 1.5 mmol) in toluene (400 mL). The reaction was stirred at 
rt until the starting material was consumed (TLC, ~ 24 h). The reaction was concentrated and the 
residue redissolved in toluene (400 mL) and triethylamine (8.5 mL). The solution was stirred for 
24 h and washed with water. The aqueous layer was then extracted with ether. The combined 
organic solution were combined, dried with Na2SO4, and concentrated under vacuum. The 
residue was purified by flash column chromatography on silica gel (5-10% EtOAc in Hex) to 
give benzyl 9-decenoate (13.1 g, 99%) as a colorless oil: Rf = 0.40 (10% EtOAc/ Hex); IR (ZnSe, 
cm-1): 3072, 2927, 2855, 1734, 1161, 908, 730 cm-1; 1H NMR: δ 7.38-7.32 (m, 5H), 5.83 (ddt, J 
= 17, 10.2, 6.6 Hz, 1H), 5.14 (s, 2H), 5.02 (ddd, J = 7.6 Hz, 2H), 5.00 (dq, , J = 17.0, 1.7 Hz, 
1H), 4.96 (d of quintet, J = 10.2, 1.2 Hz, 1H), 2.37 (t, J = 7.3 Hz, 2H), 2.10-2.02 (br q, J = 7.3 
Hz, 2H), 1.70-1.63 (br m, 2H), 1.41-1.48 (m, 10H); 13C NMR: δ 173.5, 138.9, 136.1, 128.4, 
128.1, 128.0, 114.1, 65.9, 34.2, 33.7, 28.99, 28.97, 28.8, 28.7, 24.8, 22.6, 14.0; HRESI-MS: 
calcd. for C17H24O2Na: [M+Na]+ 283.1674; Found: 283.1671. 
(Z)-9-Octadecenoate, benzyl ester (benzyl oleate) was prepared by a variation of a known 
procedure.2 Benzyl alcohol (3.83 g, 35.4 mmol) was added to a stirred solution of oleic acid 
(5.136 g, 18.1 mmol) and DMAP (43.7 mg, 3.57 mmol) in CH2Cl2 (40 mL). The solution was 
cooled to 0 °C and DCC (4.211 g, 20.4 mmol) was added. The mixture was allowed to warm to rt 
and stirred for 2.5 h. The resulting suspension was filtered through a cotton plug and the 
precipitate was washed with CH2Cl2. The CH2Cl2 solution was washed with water and dried over 
Na2SO4. Evaporation of the organic solvent and flash chromatography of the residue over silica 
gel, using 5% EtOAc/Hex, gave benzyl oleate (5.73 g, 85 %) as a colorless oil: Rf = 0.83 (10% 
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EtOAc/Hex);  IR (ZnSe, cm-1) 2924, 2853, 1738, 1456, 1162, 696 cm-1; 1H NMR: δ 7.38-7.31 
(5H), 5.41-5.31 (2H), 5.13 (s, 2H), 2.37 (t, J = 7.6 Hz, 2H), 2.05-2.00 (4H), 1.70-1.62 (m, 2H), 
1.40-1.29 (20H), 0.90 (t, J = 6.8 Hz, 3H); 13C NMR δ 173.6, 136.12, 129.9, 129.7, 128.5 (two 
overlapping signals), 128.11, 128.09, 66.0, 34.3, 31.9, 29.7, 29.6, 29.50, 29.3, 29.1, 29.1, 27.2, 
27.1, 24.9, 22.7, 14.1.  
(E)-9-octadecenoic acid, benzyl ester (benzyl elaidate)3 was prepared from the reaction of 
elaidic acid (0.9836, 3.5 mmol), DCC (0.79 g, 3.8 mmol), DMAP (0.087 g, 0.7 mmol), and 
benzyl alcohol (0.73 mL, 7 mmol) in CH2Cl2 (10 mL) by a similar procedure as employed for 
benzyl oleate. The product was purified by flash column chromatography on silica gel (2.5% / 
5% EtOAc/Hex) to afford 1.2280 g (95%) of benzyl elaidate as a colorless oil: Rf = 0.57 (10% 
EtOAc/Hex). IR (ZnSe, cm-1) 2922, 2852, 2737, 1160, 966, 696 cm-1; 1H NMR: δ 7.38-7.34 (m, 
5H), 5.41-5.38 (m, 2H), 5.13 (s, 2H), 2.37 (t, J = 7.2 Hz, 2H), 1.98 (br s, 4H), 1.68-1.63 (m, 2H), 
1.38-1.18 (br m, 20H), 0.90 (t, J = 7.2 Hz, 3H); 13C NMR δ 173.6, 136.1, 130.4, 130.2, 128.5, 
128.1, 66.0, 34.3, 32.57, 32.52, 31.9, 29.6, 29.52, 29.46, 29.3, 29.2, 29.1, 29.0, 28.9, 24.9, 22.7, 
14.1.  




Data from cytotoxicity studies 
	  
Figure S1. Analogs investigated  
Table S1.  Toxicity of Fatty acid analogs in RAW 2647 macrophages 
Compound Average % viability at indicated concentration (µM) 
0 25 50 100 250 Controla 
1 (DA-CB) 100 67.8 58.5 48.1 0.9 0.2 
2 (DA-satCB) 100 72.9 49.2 7.5 0.6 0.2 
4 (DA-alcCB) 100 86.5 78.7 77.5 58.8 0.2 
5 (OA-CB) 100 93.8 91.8 89.3 73.4 0.2 
6 (OA-satCB) 100 87.8 84.6 82.5 78.9 0.2 
8 (OA-alcCB) 100 5.5 4.4 4.4 3.7 0.2 
DA 100 83.5 77.3 73 38.3 0.2 
D-cycloserine 100 81.8 77.5 72.2 69.4 0.2 
Isoniazid 100 76.5 75.1 71.7 64 0.2 







1 2 4 decenoic acid (12)










Thermal Stability (Figure S1-S11) 
Differential scanning calorimetry (DSC) and thermal gravimetric analysis (TGA) were acquired 
simultaneously on 4-10 mg samples of the indicated molecules,  using a Perkin Elmer STA 6000 
analyzer operated at a temperature ramp of 2 °C/minute except for compound 5 at a 5 °C/minute  
Figure	  S1.	  	  Thermal	  stability	  of	  1.	  TGA-­‐measured	  mass	  (red)	  and	  DSC-­‐measured	  heat	  flow	  (blue).	  	  




Figure S2.  Thermal stability of 2. TGA-measured mass (red) and DSC-measured heat flow 
(blue).  
	  





Figure S4.  Thermal stability of 4. TGA-measured mass (red) and DSC-measured heat flow 
(blue). 
	  





Figure S6.  Thermal stability of 6. TGA-measured mass (red) and DSC-measured heat flow 
(blue). 
	  





Figure S8.  Thermal stability of 8. TGA-measured mass (red) and DSC-measured heat flow 
(blue). 
 





Figure S10.  Thermal stability of 10. TGA-measured mass (red) and DSC-measured heat flow 
(blue). 
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1 J, J. Li, C. Limberakis, D. A. Pflum, Modern Organic Synthesis in the Laboratory: A 
Collection of Standard Experimental Procedures, Oxford University Press, New York, 2007, p 
45. 
2 B. Neises, W. Steglich, Angew. Chem. Int. Ed. 1978, 17, 522–524. Previous report:  E. G. 
Maleeva, Zhurnal Obshchei Khimii 1953, 23, 1662–1664; K. Murai, G. J. Akazome, Jpn Oil 
Chem. Soc. 1955, 4, 125–127. (no detail for preparation)   
3 E. G. Maleeva, Zhurnal Obshchei Khimii. 1953, 23, 1662–1664 [Chem. Abstr. 1954, 48, 
77506]. 
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Figure S1.1. 1H-NMR (400 MHz, chloroform-d) spectrum. 
 
Figure S1.2. 13C-NMR (100 MHz, chloroform-d) spectrum. 







































































































NAME            WS-4-75
EXPNO                 1
PROCNO                1
Date_          20111121
Time              10.41
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                   18
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300090 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0







































































NAME            WS-4-75
EXPNO                 2
PROCNO                1
Date_          20111121
Time              10.51
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  186
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127806 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
SI page 22




Figure S2.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 15. 
 
Figure S2.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 15. 









































































NAME            WS-4-78
EXPNO                 1
PROCNO                1
Date_          20111121
Time              10.58
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 25.4
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300090 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0



























































NAME            WS-4-78
EXPNO                 2
PROCNO                1
Date_          20111121
Time              11.07
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  174
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127836 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S3.1. 1H-NMR (400 MHz, chloroform-d) spectrum. 
 
































































NAME            WS-4-83
EXPNO                 1
PROCNO                1
Date_          20111122
Time              11.21
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 35.9
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0



























































NAME            WS-4-83
EXPNO                 2
PROCNO                1
Date_          20111122
Time              11.29
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  151
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127777 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S4.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 16. 
 














































NAME     WS-4-84-filter
EXPNO                 1
PROCNO                1
Date_          20111128
Time              17.04
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 35.9
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300092 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0






























































NAME     WS-4-84-filter
EXPNO                 2
PROCNO                1
Date_          20111128
Time              17.13
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  155
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127806 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S5.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 1. 
 
Figure S5.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 1. 







































































NAME     WS-4-85-c1f2-dry
EXPNO                 1
PROCNO                1
Date_          20111130
Time              17.44
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 90.5
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0



















































NAME      WS-4-85-c1fr2
EXPNO                 2
PROCNO                1
Date_          20111130
Time              10.25
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  272
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127704 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S6.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 2. 
 
Figure S6.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 2. 



































































































































NAME        WS-4-88-dry
EXPNO                 1
PROCNO                1
Date_          20111206
Time              17.01
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 71.8
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
















































NAME            WS-4-88
EXPNO                 2
PROCNO                1
Date_          20111202
Time              17.40
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  115
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127704 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S7.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 17. 
 
Figure S7.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 17. 

























































NAME      WS-4-82-c1fr3
EXPNO                 1
PROCNO                1
Date_          20111121
Time              11.15
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                   18
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300088 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0





















































NAME      WS-4-82-c1fr3
EXPNO                 2
PROCNO                1
Date_          20111121
Time              11.18
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   63
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127901 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S8.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 3. 
 
Figure S8.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 3. 

























































NAME        WS-4-87-dry
EXPNO                 1
PROCNO                1
Date_          20111205
Time              13.51
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                161.3
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0































































































12 NAME        WS-4-12-col
EXPNO                 2
PROCNO                1
Date_          20110826
Time              17.11
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  255
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               2298.8
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127712 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S9.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 18. 
 
Figure S9.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 18. 













































































































NAME        WS-4-94-dry
EXPNO                 1
PROCNO                1
Date_          20111209
Time              16.08
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  362
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
























































NAME        WS-4-94-ext
EXPNO                 2
PROCNO                1
Date_          20111208
Time              15.05
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  128
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127741 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S10.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 4. 
 
































































































NAME            WS-4-96
EXPNO                 1
PROCNO                1
Date_          20111209
Time              16.18
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT            MeOD
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                161.3
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0



























































NAME            WS-4-96
EXPNO                 2
PROCNO                1
Date_          20111209
Time              16.36
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT            MeOD
NS                  545
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               4597.6
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127690 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S11.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 19. 
 
 
Figure S11.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 19. 















































































































































































NAME            WS-2-50
EXPNO                 1
PROCNO                1
Date_          20100409
Time              10.55
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 40.3
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00


















































































































54 NAME            WS-2-50
EXPNO                 2
PROCNO                1
Date_          20100409
Time              11.04
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  278
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1149.4
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127740 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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NAME        WS-2-81-col
EXPNO                 1
PROCNO                1
Date_          20100615
Time              11.40
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 90.5
DW               60.400 usec
DE                 6.50 usec
TE                294.1 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
















Figure S12.2. 1H-NMR (400 MHz, chloroform-d) spectrum of first eluting cis isomer. 
 
Figure S12.3. 13C-NMR (100 MHz, chloroform-d) spectrum of first eluting cis isomer. 









































































































































































NAME        WS-2-58-fr2
EXPNO                 1
PROCNO                1
Date_          20100514
Time              18.28
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 90.5
DW               60.400 usec
DE                 6.50 usec
TE                293.5 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
















































































NAME        ws-2-51-fr3
EXPNO                 2
PROCNO                1
Date_          20100416
Time              21.58
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  582
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1149.4
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127711 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S12.4. 1H-NMR (400 MHz, chloroform-d) spectrum of first eluting trans isomer. 
 
Figure S12.5. 13C-NMR (100 MHz, chloroform-d) spectrum of first eluting tran isomer. 

































































































































































































NAME      WS-2-92-hplc2
EXPNO                 1
PROCNO                1
Date_          20100618
Time              15.54
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                322.5
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0















































































64 NAME      WS-2-92-hplc2
EXPNO                 2
PROCNO                1
Date_          20100618
Time              16.11
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  593
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1149.4
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
ND0                   2
TD                  128
SFO1           500.1325 MHz
FIDRES        39.062500 Hz
SW                9.997 ppm
FnMODE      States-TPPI
SI                32768
SF          100.6127704 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
SI                 1024
MC2         States-TPPI
SF          500.1300000 MHz
WDW               QSINE
SSB                   2
LB                 0.00 Hz
GB                    0
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Figure S12.6. 1H-NMR(400 MHz, chloroform-d) spectrum of second eluting cis isomer. 
 
Figure S12.7. 13C-NMR(100 MHz, chloroform-d)spectrum of second eluting cis isomer. 




































































































































































































NAME        WS-2-58-fr4
EXPNO                 1
PROCNO                1
Date_          20100514
Time              18.35
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                   64
DW               60.400 usec
DE                 6.50 usec
TE                293.5 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
















































































NAME        ws-2-51-fr5
EXPNO                 2
PROCNO                1
Date_          20100416
Time              22.44
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  274
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG                812.7
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127719 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S12.8. 1H-NMR(400MHz, chloroform-d)spectrum of second eluting trans isomer. 
 
Figure S12.9. 13C-NMR(100MHz,chloroform-d) spectrum of second eluting trans isomer. 
































































































































































NAME      WS-2-92-hplc4
EXPNO                 1
PROCNO                1
Date_          20100618
Time              17.53
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                322.5
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
















































































NAME      WS-2-92-hplc4
EXPNO                 3
PROCNO                1
Date_          20100618
Time              18.45
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                 1055
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1149.4
DW               20.850 usec
DE                 6.50 usec
TE                298.1 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127704 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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NAME      WS-2-67-crude
EXPNO                 1
PROCNO                1
Date_          20100521
Time              21.37
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 90.5
DW               60.400 usec
DE                 6.50 usec
TE                293.6 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI               131072
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.60 Hz
GB                    0
PC                 1.00
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Figure S13.2. 1H-NMR (400 MHz, chloroform-d) spectrum of first eluting trans isomer of 20.
 
Figure S13.3. 13C-NMR(100 MHz, chloroform-d) spectrum of first eluting trans isomer of 20. 





























































































































































NAME      WS-2-93-hplc1
EXPNO                 1
PROCNO                1
Date_          20100619
Time              11.34
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  256
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0






















































































NAME      WS-2-93-hplc1
EXPNO                 2
PROCNO                1
Date_          20100619
Time              12.25
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                 2048
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG                645.1
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127704 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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FigureS13.4. 1H-NMR(400MHz,chloroform-d)spectrum of second eluting trans isomer of 20.
 
FigureS13.5.13C-NMR(100MHz,chloroform-d)spectrum of second eluting trans isomer of 20. 



























































































































































































NAME      WS-2-93-hplc2
EXPNO                 1
PROCNO                1
Date_          20100619
Time              21.22
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   32
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  362
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0






















































































NAME      WS-2-93-hplc2
EXPNO                 2
PROCNO                1
Date_          20100619
Time              21.55
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                11500
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG                 1024
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127704 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S13.6. 1H-NMR (400 MHz, chloroform-d) spectrum of first eluting cis isomer of 20. 
 
Figure S13.7. 13C-NMR (100 MHz, chloroform-d) spectrum of first eluting cis isomer of 20. 






















































































































NAME      WS-2-67-HPLC4
EXPNO                 1
PROCNO                1
Date_          20100522
Time              16.48
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                   32
DW               60.400 usec
DE                 6.50 usec
TE                294.3 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0



















































































NAME      WS-2-67-HPLC4
EXPNO                 2
PROCNO                1
Date_          20100522
Time              16.56
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   87
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1149.4
DW               20.850 usec
DE                 6.50 usec
TE                295.1 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127770 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
SI page 41




Figure S13.8. 1H-NMR(400 MHz, chloroform-d) spectrum of second eluting cis isomer of 20. 
 
Figure S13.9. 13C-NMR(100 MHz, chloroform-d)spectrum of second eluting cis isomer of 20. 


























































































































































NAME      WS-2-67-HPLC7
EXPNO                 1
PROCNO                1
Date_          20100522
Time              17.19
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 35.9
DW               60.400 usec
DE                 6.50 usec
TE                294.4 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0






















































































NAME      WS-2-67-HPLC7
EXPNO                 2
PROCNO                1
Date_          20100522
Time              17.28
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  127
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1149.4
DW               20.850 usec
DE                 6.50 usec
TE                295.2 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127770 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S20.1. 1H-NMR (400 MHz, chloroform-d) spectrum of compound 5. 
 
Figure S20.2. 13C-NMR (100 MHz, chloroform-d) spectrum of compound 5. 














































NAME            WS-4-63
EXPNO                 1
PROCNO                1
Date_          20120110
Time              11.34
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  256
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0













































































NAME       ws-1-16-c1f1
EXPNO                 2
PROCNO                1
Date_          20081021
Time              17.45
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  116
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1149.4
DW               20.850 usec
DE                 6.50 usec
TE                294.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 9.50 usec
PL1                0.00 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              13.82 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127722 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S21.1. 1H-NMR (400 MHz, chloroform-d) spectrum of compound 6. 
 
Figure S21.2. 13C-NMR (100 MHz, chloroform-d) spectrum of compound 6. 







































































































NAME            WS-4-89
EXPNO                 1
PROCNO                1
Date_          20111202
Time              17.49
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 45.3
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0








































































NAME            WS-4-89
EXPNO                 2
PROCNO                1
Date_          20111202
Time              18.00
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  175
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1290.2
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127697 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S22.1. 1H-NMR (400 MHz, chloroform-d) spectrum of compound 21. 
 
Figure S22.2. 13C-NMR (100 MHz, chloroform-d) spectrum of compound 21. 




































































































































































































NAME             WS-3-5
EXPNO                 1
PROCNO                1
Date_          20100728
Time              15.37
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 40.3
DW               60.400 usec
DE                 6.50 usec
TE                294.9 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00










































































































NAME             WS-3-5
EXPNO                 2
PROCNO                1
Date_          20100728
Time              15.48
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  166
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG                812.7
DW               20.850 usec
DE                 6.50 usec
TE                295.8 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127748 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S23.1. 1H-NMR (400 MHz, chloroform-d) spectrum of compound 7.
 
Figure S23.2. 13C-NMR (100 MHz, chloroform-d) spectrum of compound 7. 




































































NAME            WS-6-45
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20130123
Time              14.18
INSTRUM           spect
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8012.820 Hz
FIDRES         0.122266 Hz
AQ            4.0894465 sec
RG               112.19
DW               62.400 usec
DE                 6.50 usec
TE                298.1 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1331310 MHz
NUC1                 1H
P1                11.00 usec
PLW1        12.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1306678 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00


























































































12 NAME        WS-4-12-col
EXPNO                 2
PROCNO                1
Date_          20110826
Time              17.11
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  255
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               2298.8
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127712 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S24.1. 1H-NMR (400 MHz, chloroform-d) spectrum. 
 
Figure S24.2. 13C-NMR (100 MHz, chloroform-d) spectrum. 


























































































































































NAME        WS-4-93-ext
EXPNO                 1
PROCNO                1
Date_          20111208
Time              11.51
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 45.3
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00




























































































































NAME        WS-4-93-ext
EXPNO                 2
PROCNO                1
Date_          20111208
Time              15.25
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  203
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG                 2048
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127730 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S25.1. 1H-NMR (400 MHz, chloroform-d) spectrum of compound 8. 
 
Figure S25.2. 13C-NMR (100 MHz, chloroform-d) spectrum of compound 8. 





























































































































































NAME            WS-4-95
EXPNO                 1
PROCNO                1
Date_          20111209
Time              14.35
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 71.8
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00











































































































































NAME            WS-4-95
EXPNO                 2
PROCNO                1
Date_          20111209
Time              14.52
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  658
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127704 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0















Figure S26.1. 1H-NMR (400 MHz, chloroform-d) spectrum of compound 22. 
 
Figure S26.2. 13C-NMR (100 MHz, chloroform-d) spectrum of compound 22. 











































































































NAME     WS-6-41-c1f11-17
EXPNO                 1
PROCNO                1
Date_          20121031
Time              11.23
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                   32
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300092 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00




























































































































NAME     WS-6-41-c1f11-17
EXPNO                 2
PROCNO                1
Date_          20121031
Time              11.36
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  436
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG              11585.2
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127763 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S27.1. 1H-NMR (400 MHz, chloroform-d) spectrum of compound 9. 
 
Figure S27.2. 13C-NMR (100 MHz, chloroform-d) spectrum of compound 9. 



























































































NAME     WS-6-57-col-COSY
EXPNO                 1
PROCNO                1
Date_          20121106
Time              15.52
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                32768
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            5995.204 Hz
FIDRES         0.182959 Hz
AQ            2.7329011 sec
RG                 45.3
DW               83.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1                2.20 dB
SFO1        300.1318534 MHz
SI                32768
SF          300.1300061 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0





























































































NAME     WS-6-57-col-dry
EXPNO                 3
PROCNO                1
Date_          20121105
Time              18.25
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  768
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               7298.2
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127726 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S28.1. 1H-NMR (400 MHz, chloroform-d) spectrum. 
 
Figure S28.2. 13C-NMR (100 MHz, chloroform-d) spectrum. 











































NAME            WS-4-16
EXPNO                 1
PROCNO                1
Date_          20121019
Time              11.24
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 22.6
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300092 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00









































































NAME            WS-4-16
EXPNO                 2
PROCNO                1
Date_          20121019
Time              11.27
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   56
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG                 6502
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127740 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S29.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 23. 
 
Figure S29.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 23. 

















































































NAME        WS-6-37-col
EXPNO                 1
PROCNO                1
Date_          20120919
Time              21.52
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                32768
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            5995.204 Hz
FIDRES         0.182959 Hz
AQ            2.7329011 sec
RG                 35.9
DW               83.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1                2.20 dB
SFO1        300.1318534 MHz
SI                32768
SF          300.1300063 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00

























































































































NAME        WS-6-37-col
EXPNO                 2
PROCNO                1
Date_          20120919
Time              22.07
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                32768
SOLVENT           CDCl3
NS                  272
DS                    4
SWH           17985.611 Hz
FIDRES         0.548877 Hz
AQ            0.9110004 sec
RG                13004
DW               27.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                5.20 dB
SFO1         75.4752953 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2                2.20 dB
PL12              19.10 dB
PL13              19.10 dB
SFO2        300.1312005 MHz
SI                32768
SF           75.4677545 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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NAME        WS-6-59-ext
EXPNO                 1
PROCNO                1
Date_          20121107
Time              15.46
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 35.9
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
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Figure S30.2. 1H-NMR (400 MHz, chloroform-d) spectrum of first eluting trans isomer. 
 
Figure S30.3. 13C-NMR(100 MHz, chloroform-d) spectrum of first eluting trans isomer. 



























































































NAME      WS-6-59-c1f10
EXPNO                 1
PROCNO                1
Date_          20121119
Time              19.40
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  362
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
















































































NAME     WS-6-59-c1f10-NOESY
EXPNO                 3
PROCNO                1
Date_          20121211
Time              14.56
INSTRUM           spect
PROBHD   5 mm PABBO BB/
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  205
DS                    4
SWH           24038.461 Hz
FIDRES         0.366798 Hz
AQ            1.3631988 sec
RG               210.59
DW               20.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        100.6229953 MHz
NUC1                13C
P1                 9.00 usec
SI                32768
SF          100.6129362 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S30.4. 1H-NMR (400 MHz, chloroform-d) spectrum of first eluting cis isomer. 
 
Figure S30.5. 13C-NMR (100 MHz, chloroform-d) spectrum of first eluting cis isomer. 

























































NAME      WS-6-59-c1f15
EXPNO                 1
PROCNO                1
Date_          20121119
Time              19.47
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  362
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
















































































NAME     WS-6-59-c1f15-C_NOESY
EXPNO                 2
PROCNO                1
Date_          20121211
Time              16.00
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                32768
SOLVENT           CDCl3
NS                  511
DS                    4
SWH           17985.611 Hz
FIDRES         0.548877 Hz
AQ            0.9110004 sec
RG               7298.2
DW               27.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                5.20 dB
SFO1         75.4752953 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2                2.20 dB
PL12              19.10 dB
PL13              19.10 dB
SFO2        300.1312005 MHz
SI                32768
SF           75.4677501 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S30.6. 1H-NMR (400 MHz, chloroform-d) spectrum of second eluting trans isomer. 
 
Figure S30.7.13C-NMR (100MHz, chloroform-d) spectrum of second eluting trans isomer. 

























































NAME      WS-6-59-c1f20
EXPNO                 1
PROCNO                1
Date_          20121119
Time              19.53
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                456.1
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00















































































NAME     WS-6-59-c1f20_C
EXPNO                 2
PROCNO                1
Date_          20121211
Time              17.05
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                32768
SOLVENT           CDCl3
NS                 2048
DS                    4
SWH           17985.611 Hz
FIDRES         0.548877 Hz
AQ            0.9110004 sec
RG                13004
DW               27.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                5.20 dB
SFO1         75.4752953 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2                2.20 dB
PL12              19.10 dB
PL13              19.10 dB
SFO2        300.1312005 MHz
SI                32768
SF           75.4677496 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S30.8. 1H-NMR (400 MHz, chloroform-d) spectrum of second eluting cis isomer. 
 
Figure S30.9. 13C-NMR (100 MHz, chloroform-d) spectrum of second eluting cis isomer. 















































NAME      WS-6-59-c1f23
EXPNO                 1
PROCNO                1
Date_          20121119
Time              19.59
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                228.1
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0

























































































NAME     WS-6-59-c1f23-NOESY
EXPNO                 4
PROCNO                1
Date_          20121211
Time              11.56
INSTRUM           spect
PROBHD   5 mm PABBO BB/
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  409
DS                    4
SWH           24038.461 Hz
FIDRES         0.366798 Hz
AQ            1.3631988 sec
RG               210.59
DW               20.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        100.6229953 MHz
NUC1                13C
P1                 9.00 usec
SI                32768
SF          100.6129391 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S31.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 24. 
 
Figure S31.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 24. 



































































































































NAME        WS-6-77-col
EXPNO                 1
PROCNO                1
Date_          20121214
Time              16.38
INSTRUM           spect
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8012.820 Hz
FIDRES         0.122266 Hz
AQ            4.0894966 sec
RG                   32
DW               62.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1331310 MHz
NUC1                 1H
P1                11.00 usec
SI                65536
SF          400.1306678 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
































































































































































NAME        WS-6-77-col
EXPNO                 2
PROCNO                1
Date_          20121214
Time              16.44
INSTRUM           spect
PROBHD   5 mm PABBO BB/
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  174
DS                    4
SWH           24038.461 Hz
FIDRES         0.366798 Hz
AQ            1.3631988 sec
RG               210.59
DW               20.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        100.6229953 MHz
NUC1                13C
P1                 9.00 usec
SI                32768
SF          100.6129399 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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Figure S32.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 10. 
 
Figure S32.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 10. 











































NAME        ws-2-28-fr2
EXPNO                 1
PROCNO                1
Date_          20100303
Time              15.27
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  181
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                12.00 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
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Figure S33.1. 1H-NMR (400 MHz, chloroform-d) spectrum. 
 
Figure S33.2. 13C-NMR (100 MHz, chloroform-d) spectrum. 





























































































NAME        WS-6-40-col
EXPNO                 1
PROCNO                1
Date_          20121031
Time              15.55
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 28.5
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300093 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00






































































































































































NAME        WS-6-40-col
EXPNO                 2
PROCNO                1
Date_          20121031
Time              16.02
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  390
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               7298.2
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127763 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
SI page 60




Figure S34.1. 1H-NMR (400 MHz, chloroform-d) spectrum of 11. 
 
Figure S34.2. 13C-NMR (100 MHz, chloroform-d) spectrum of 11. 



































































































































NAME        WS-2-74-ext
EXPNO                 1
PROCNO                1
Date_          20100604
Time              12.11
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 40.3
DW               60.400 usec
DE                 6.50 usec
TE                294.2 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.25 usec
PL1               -3.35 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300095 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00





























































































































































NAME            WS-6-46
EXPNO                 2
PROCNO                1
Date_          20120925
Time              18.38
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  594
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1149.4
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.00 dB
PL12              12.90 dB
PL13              12.90 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127718 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
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